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1. Introduction 
 
 
 
1.1 Integrins 
 
Cell-cell and cell-extracellular matrix (ECM) contacts are mediated by cell 
adhesion molecules (CAMs). These molecules are located on the surface of cells 
and belong to different families such as integrins, cadherins and transmembrane 
proteoglycans. Integrins are transmembrane proteins consisting of an α- and a β-
subunit. To date, 18 α- and 8 β-subunits have been found which can 
heterodimerize in different combinations to form, as known so far, 24 different 
integrins with distinct ligand binding and signalling properties (Fig.1). The β1 
integrin subunit can associate with 12 different α-subunits, thus forming the 
largest integrin subfamily (Hynes, 1992, 2002). 
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Figure 1: The integrin superfamily 
Eight β integrin subunits associate with 18 α subunits in a noncovalent fashion giving rise 
to 24 heterodimeric cell surface receptors that can bind to ECM proteins and other cell 
surface molecules.  
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With the extracellular domain integrins of the β1 subfamily bind to different ECM 
proteins like collagens (α1β1, α2β1, α10β1), laminins (α3β1, α6β1, α7β1), 
vitronectin (αvβ1) and fibronectin (FN) (α3β1, α4β1, α5β1, α8β1, αvβ1) and to 
cell surface receptors like VCAM-1 (α4β1) (Fig. 2). Integrins α4β1 and α4β7 
bind to FN, VCAM-1 and MAdCAM-1. The respective affinities, however, differ. 
Whereas α4β1 binds 30-45 fold stronger to VCAM-1 than to MAdCAM-1, α4β7 
favours interaction with MAdCAM-1 by 3-15 folds over VCAM-1 (Day et al., 
2002).  
 
 
 
Figure 2: β1 and β7 integrins and their ligands 
Integrin β1 and β7 subunits can heterodimerize as depicted by the lines recognizing the 
listed ligands, respectively. Col = collagen; FN = fibronectin; FN-alt = fibronectin 
alternatively spliced region; LN = laminin; VN = vitronectin. 
 
While β1 integrin is ubiquitously expressed, other integrin subunits are 
predominantly found in certain tissues or cell populations. Integrin β7, for 
example, is exclusively found on white blood cells (Wagner et al., 1996) whereas 
β2 integrins are specifically expressed on leukocytes and associates with αL 
(lymphocyte function associated antigen-1 (LFA-1), αM (Mac-1), αX and αD 
subunits. Important ligands of β2 integrins include members of the ICAM-family. 
In addition, Mac-1 binds also to inactivated complement factor (iC3b), fibronectin 
and factor-X, αXβ2 to iC3b and type I collagen and αDβ2 to VCAM-1 (Plow et 
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al., 2000). The αv integrins which associate with β1, β3, β5, β6 and β8 bind to 
fibronectin and to vitronectin, except for αvβ8 which binds to fibronectin, 
vitronectin and fibrin (Chernuosov et al., 2003), and αvβ6 which additionally 
binds to tenascin-C and the latent form of TGF-β called the small latent complex. 
This procytokine is composed of the C-terminal TGF-β noncovalently linked to 
the latency-associated peptide (LAP) and inactive. Binding of αvβ6 to LAP leads 
to TGF-β activation which in turn modulates inflammatory cell function, growth 
inhibition and differentiation. 
Integrin α subunits share a 25% amino acid identity. Some α-subunits, but not α4 
integrin, contain an “Inserted” or “I-domain” or “von Willebrand factor A 
domain”. I domains contain the major ligand binding sites and the metal ion-
dependent adhesion site (MIDAS) which binds divalent cations that are important 
for integrin function.  
There is an overall 37-45% amino acid identity between the β subunits with 
highest homology in the cytoplasmic and transmembrane domains. At the N-
terminus, a cysteine-rich region shows sequence homology with membrane 
proteins including plexins and semaphorins. This region is therefore called the PSI 
domain for “plexins, semaphorins, and integrins”. These cysteine-rich regions 
cooperate to restrain the integrin to the inactive conformation. Another 
evolutionarily conserved extracellular domain of β chains has about 240 residues, 
spanning from residue 100 to 340. Within this domain lays a putative metal-
binding DXSXS sequence motif similar to that of the MIDAS in the I domain, 
which is therefore called the I-like domain. This region is involved in ligand 
binding and mediates association with the α subunit (Bajt et al., 1994, Wardlaw et 
al., 1990, Michishita et al., 1993, Ueda et al., 1994 and Rieu et al., 1994). The 
gene pactolus, probably derived from a duplication of β2 integrin (Garrison S. et 
al., 2001), demonstrates the importance of this motif.  This gene contains a point 
mutation in its DXSXS region and, as a result, pactolus does not associate with an 
α subunit. Therefore pactolus is not considered as an integrin. While it is believed 
that integrins are expressed only as heterodimers on the cell surface (Whittaker 
and Hynes 2002), there are two reports that suggest that α4 in a B cell lymphoma 
cell line (Crowe et al., 1994) and α4 and α6 in a T cell lymphoma cell line 
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(Stroeken et al 1998) were present on the cell surface in the absence of any β 
subunit. No function could be addressed to these α chains on the cell surface. 
The overall shape of the extracellular integrin dimer is a globular, ligand binding 
headpiece composed of both subunits. Two long stalk regions containing C-
terminal cytoplasmic domains connect the headpiece to the transmembrane region 
of the α- and β-subunits, respectively (Fig. 3; reviewed by Shimaoka, Takagi, and 
Springer 2002). Recent studies revealed that integrins can occur in an open and in 
a closed conformation and it is believed that these two conformations correspond 
to the ligand-bound and unbound form, respectively. In it unbound form, integrins 
adopt a bent conformation (Fig. 3, left panel). Ligand binding or conformational 
changes of the cytoplasmic domains lead to straightening and separation of the 
extracellular legs, allowing high affinity interaction with ligands (right). The open 
form allows ligand binding on the outside and the association of intracellular 
proteins inside the cell (reviewed by Hynes 2002). Integrins not containing an I 
domain, such as α4 and αv integrins, adopt similar conformations as shown in the 
crystal structure for αvβ3 (Xiong et al., 2001). 
 
Figure 3: Arrangement of extracellular domains in the closed (left) and open (right) 
conformation according to αvβ3 crystal structure, with an I domain added (modified 
from Shimaoka et al., 2002) 
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Integrins in the inactive state occur in a bent (closed) conformation (left), while ligand 
binding or the association of intracellular molecules, mostly to the β chain, unfolds the 
receptor to the open conformation, which is upright with separated legs (right). 
 
Different integrin heterodimers bind different extracellular ligands and induce 
different signalling pathways. However, since integrins also crosstalk with each 
other such that signalling by one integrin influences the affinity, avidity or 
signalling of other integrin receptors, integrin functions are dependent on the 
specific integrin composition of a cell. 
Integrins are connected via linker molecules to the actin cytoskeleton inside the 
cell mainly via the β subunit. Thus by connecting the cytoskeleton to the ECM, 
integrins promote shape changes and migration of cells. They furthermore 
contribute to the mechanical stability of tissues. In addition to this structural role, 
integrins are also capable of transducing signals across the cell membrane in 
either direction. The binding of the extracellular ligands elicit signals inside the 
cell (outside-in signalling), which can promote migration, induce cell cycle 
progression, and prevent apoptosis. Since integrins, with the exception of β4, have 
only short intracellular domains without enzymatic activities, these signalling 
processes are initiated by the ligand induced association of the intracellular 
domain with signalling and adapter molecules. Ligand binding to integrins 
stimulates different intracellular signalling pathways, such as the activation of 
MAP kinases (Erk, JNK, p38), Rho GTPases, phosphoinositide 3-OH kinase (PI3-
K) and calcium influx, which trigger changes in protein activities or gene 
expression (for review see Brakebusch and Fässler). Talin links the cytoplasmic 
tail of β integrins to the cytoskeleton and serves, in addition, as a platform for 
other scaffolding and signalling molecules as it binds phosphatidyinositol 
phosphate kinase type Iγ (PIPKIγ) (de Pereda et al., 2005), Phosphatidylinositol 
(4,5) bisphosphate (PIP2) (Ling et al., 2002), vinculin (Fillingham 2005) and focal 
adhesion kinase (FAK) (Chen et al., 1995) a non-receptor tyrosine kinase. 
Activation of FAK, via src or indirectly via integrin clustering plays a central role 
in integrin signalling as it promotes cell movement by activation of PI3-K and 
Rac1 and contributes to focal adhesion formation in a positive feedback 
mechanism (Fig.4). 
1. Introduction 6Figure 4: Formation of focal contacts involves extracellular and intracellular proteins 
Matrix binding promotes integrin clustering, association with the cytoskeleton and 
activation of the focal adhesion kinase (FAK). This in turn promotes further integrin 
clustering and matrix organisation in a positive feedback mechanism. (RGD, Arg-Gly-
Asp integrin binding motif; Tal, talin; Pax, paxillin; Vin, vinculin; CAS, p130CAS; 
Giancotti and Ruoslahti 1999). 
 
Integrin signalling can promote survival by activation of PI-3K. This activation 
inhibits apoptosis by activation of Akt which then blocks several cell death 
pathways (Faraldo et al., 2001). Activation of Erk was also described to prevent 
apoptosis, however, therefore the additional activation of Rac1 mediated via FAK 
might be necessary (Cho and Klemke 2000). In the absence of growth factors 
integrin mediated activation of JNK promoted cell survival of fibroblasts in a 
FAK-dependent, but Akt- and Erk-independent manner, while in the presence of 
growth factors this survival signal was mediated via PI3-K and Akt (Almeida et 
al., 2000). 
Also the integrin-linked kinase (ILK) was reported to contribute to cell survival 
by phosphorylation of Akt (Persad et al., 2001) (Fig.5). 
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Figure 5: integrin signalling can promote survival 
Integrins mediate activation of FAK, PI3-K and ILK and thereby contribute to cell 
survival and promote progression of the cell cycle. 
 
ILK was described to directly bind to β1 and β3 integrin chains (Hannigan et al., 
1996). Although ILK was shown in over-expression studies to induce 
phosphorylation of GSK-3β and Akt (Delcommenne et al., 1998) it is not clear 
whether this kinase activity is necessary for its biological function since ILK-
deficient fibroblasts and chondrocytes did not show altered phosphorylation levels 
of GSK-3β and Akt (Sakai et al., 2003; Grashoff et al., 2003). It therefore seems 
likely that ILK exerts its function mainly by linking integrins to actin filaments 
and to signalling molecules such as paxillin, which was shown to bind α4 integrin 
directly (Liu et al., 1999), and PINCH (Fig. 6) (reviewed by Brakebusch and 
Fässler, 2003). It might also allow crosstalk between integrins and growth factor 
receptors by binding to receptor tyrosine kinases via PINCH and Nck-2. 
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Figure 6: ILK provides a link between integrins and the actin cytoskeleton 
Beta integrins bind ILK which, upon extracellular ligand binding, recruits several adaptor 
proteins that modulate actin dynamics and actin attachment to the integrin adhesion site. 
 
FAK activation can promote cell cycle progression. Since FAK can be activated 
by integrins and by growth factor receptors, it is an important integration point of 
integrin and growth factor receptor signalling. Another integration point between 
these signalling pathways is that of the Rho-GTPases which can be activated by 
integrins and growths factor receptors by stimulation of guanine nucleotide 
exchange factors (GEFs) such as vav (Fig.7). Rho GTPases are crucial for the 
organization of the cytoskeleton, thereby influencing adhesion and migration 
(reviewed by Bishop et al., 2000). In addition, Rho GTPases are also regulating 
cell polarity, secretion, endocytosis, proliferation, survival and cell-cell contacts. 
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c igure 7: Crosstalk between integrin signalling and growth factor receptor signalling via 
ho-GTPases. 
ntegrins and growth factor receptors can activate ERK and JNK via Rho-GTPases and 
hus modulate proliferation and survival of cells. 
 remarkable feature of integrins in comparison to other adhesion molecules is 
hat their ability to bind ligands is regulated by intracellular signalling. 
ntracellular processes can regulate the extracellular binding activity of integrins 
inside-out signalling). The binding of talin to the cytoplasmic tail of inactive 
closed conformation) β subunit, for example, leads to a separation of the 
ytoplasmic domains of the α- and β-chain and is accompanied by conformational 
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changes in them. This in turn straightens the extracellular stalk regions and opens 
the conformation of the integrin allowing ligand binding at the extracellular side. 
Also chemokine signalling leads to a quick upregulation of integrin affinity, 
which is essential for the extravasation of blood cells into inflammed tissues. In 
addition, changes in the cytoskeleton, which lead to the clustering of the 
associated integrins, enhance the binding strength of integrin receptors by 
increasing the avidity. Finally, it was shown that also modulation of lateral 
mobility of integrins can be crucial for cell attachment.  
Within a migrating cell new contacts need to be formed at the front, while the rear 
of the cell has to detach. Locking integrins into a high affinity state would prevent 
rear cell detachment and inhibit migration. Therefore disassembly of focal 
contacts and down regulation of integrin affinity and avidity via inside-out 
signalling at the rear of the cell are indispensable for the migration of cells. This 
implies that integrin activity is regulated differentially in different regions of a 
single cell. In migrating leukocytes, activation of RhoA mediates the detachment 
at the rear by decreased adhesion of α4β1 and β2 integrins (Worthylake et al., 
2001).  
 
 
 
1.2 Development of the hematopoietic system 
 
All blood cells derive from hematopoietic stem cells (HSCs) which have the 
potential to self-renew and to differentiate into all hematopoietic lineages (Fig. 8). 
HSCs are generated outside the embryo proper, in the yolk sac (YS) and within 
the embryo in the para-aortic splanchnopleura (PAS)/aorta-gonad mesonephros 
(AGM) region. At around E8.5 when circulation starts in mouse, the HSCs are 
present in the fetal blood and at E10 start to colonize the fetal liver, which is the 
organ of hematopoiesis during embryonic life (reviewed by Morrison et al., 1995; 
Weissman 1994, Kondo et al., 2003). Later, hematopoietic progenitors seed the 
thymus, the spleen, other lymphoid organs and the bone marrow (BM) where 
blood cell development occurs in adulthood. In the adult mouse HSCs represent 
up to 0.05% of cells of the BM. HSC give rise to lymphatic, myeloid and 
erythroid precursor cells. Different cell types and developmental stages can be 
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distinguished by the expression of characteristic cell surface markers (Fig. 8). 
HSCs are described by a combination of marker proteins and defined by their 
ability to give rise to long-term multilineage reconstitution in lethally irradiated 
mice. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Cells of the hematopoietic system 
All hematopoietic cells derive from hematopoietic stem cells (HSCs) that give rise to 
common lymphoid precursors (CMPs) and common myeloid precursors (CLPs), which 
further differentiate into different mature cell types. While lineage committed cells can be 
described upon their expression of certain markers on the cell surface, HSCs and 
precursor cells are usually identified by a combination of several surface markers 
(modified from Weissman et al., 2003).  
 
 
 
Lymphoid development 
 
Lymphocytes are responsible for the acquired immunity and the immunologic 
attributes of diversity, specifity, memory and self/nonself recognition. They 
continuously circulate in the blood and lymph, are capable of homing to 
secondary lymphoid organs and migrate into tissues. In mice, lymphocytes 
constitute 20%-40% of the blood leukocytes. During their development from 
CLPs, lymphoid cells become restricted either to the B cell, T cell or the NK cell 
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lineage. While B cells and NK cells develop within the BM, T cell precursors 
leave the BM, migrate to the thymus and mature there.  
The course of B cell development is characterized by the expression of specific 
surface markers that characterize certain developmental stages (Fig.9). The first 
lineage specific marker B cells express is B220 (CD45R). This surface molecule 
is expressed at all stages from pre-pro B cells throughout mature stages and on 
activated B cells. After emigration from the BM, immature B cells increase B220 
expression from medium (B220med) to high levels (B220hi) and become mature 
B cells. B220hi cells in the BM, therefore, are recirculating B cells from the 
periphery. CD19 is a member of the immunoglobulin superfamily and is 
expressed from the pro B cell stage throughout B cell development. IgM is present 
on immature B cells after the V, D, J rearrangements of the genes of the 
immunoglobulin heavy and light chains. In early mature cells a change in RNA 
processing of the heavy-chain primary transcript leads to production of two 
mRNAs encoding IgM and IgD. These cells leave the BM, enter the blood and 
subsequently home to peripheral lymphoid organs where the expression of 
membrane bound IgD increases. 
 
 
 
 
 
 
 
 
 
 
 
 
Immature
B cell 
Pre- 
B cell
Pro- 
B cell
B220m, CD19+
B220h, CD19+, 
IgMlow, IgD+
B220m, CD19+
B220m, CD19+, 
IgM+
B220m, CD19-
Pre-Pro- 
B cell 
Lymphoid 
 Precursor 
 
Mature 
B cell  
Figure 9: B cell development is accompanied by the expression of characteristic surface 
molecules. 
B cell development occurs in the BM and originates from lymphoid progenitor cells. The 
expression of the surface markers B220, CD19, IgM and IgD are characteristic for a 
certain developmental stage on during B cell development. Mature B cells leave the BM 
and are found in the periphery.  
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T cell precursors leave the BM, enter the blood stream and then colonize the 
cortex (outer compartment) of the thymus. These precursors do not express 
molecules characteristic for mature T cells like CD4, CD8 or the T cell receptor 
complex. In the thymus, the T cell precursors are part of the so-called double 
negative (DN; CD4-CD8-) population. Other markers like c-kit, CD44 and CD25 
allow subdividing the DN population into sequential developmental stages. 
Subsequent to switching off c-kit and reducing CD44 expression T cells start to 
rearrange their TCR genes. The majority of the thymocytes rearrange the TCR β-
chain genes. Newly synthesized β-chains combine with the pre T α-chain and 
associate with the CD3 group to form a novel complex called the pre-T cell 
receptor (pre-TCR). The pre-TCR is thought to interact with an intrathymic ligand 
and to transmit a signal through the CD3 complex. This signal induces 
developmental progression to the CD4+CD8+ double positive (DP) state. At this 
stage T cells proliferate and undergo positive and negative selection restricting 
survival to MHC-restricted, self-tolerant T cells. During this process, DP T cells 
migrate from the cortex to the medulla (inner compartment of the thymus) and 
develop into either single positive (SP) CD4+ T cells or SP CD8+ T cells. SP T 
cells leave the thymus through postcapillary venules and home to secondary 
lymphoid organs and BM. The intrathymic development takes about 3 weeks, of 
which 2 weeks are at the DN, 3-4 days at the DP, and up to 2 days at the SP stage. 
Naive T cells are thought to survive about 5-7 weeks in the absence of antigen-
stimulated activation. 
Thymocytes with productive rearrangements of both the γ- and δ-chain genes 
develop into CD4, CD8 double negative CD3+ γδ T cells. These cells move to the 
periphery and account for less than 5% of thymocytes in adult mice. 
 
 
 
Myeloid and erythroid cells 
 
Common myeloid precursors (CMPs) develop either into 
megakaryocyte/erythrocyte progenitors (MEPs) or into granulocyte/monocyte 
precursor cells (GMPs). MEPs develop either into megakaryocytes to form 
platelets or into erythroblasts and later erythrocytes. GMPs give rise to both 
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granulocytes and monocytes, which mature into macrophages as soon as they 
leave the blood stream and enter tissues. Granulocytes can be subdivided on the 
basis of cellular morphology into neutrophils, eosinophils and basophils. 
Neutrophils and eosinophils are phagocytotic, whereas basophils are not. 
Neutrophils, besides macrophages are the major phagocytotic cells of the mouse. 
They are generated in the BM, released into the peripheral blood and circulate for 
7-10h until they migrate into tissues, where they have a life span of a few days. 
Neutrophils constitute 50%-70% of the circulating white blood cells in mice and 
are much more numerous than eosinophils (1%-3%) or basophils (<1%). Because 
of their multilobed nucleus, neutrophils are often called polymorphonuclear 
leukocytes (PMN). Granulocytes can be detected by their expression of Gr-1 (Ly-
6G). In the BM the Gr-1 expression level is directly correlated to the granulocyte 
differentiation and maturation. Also monocytes express this marker transiently in 
the BM, while in the periphery Gr-1 is expressed only on neutrophils.  
Monocyte development starts in the BM. Promonocytes then leave the BM and 
enter the blood, where they enlarge and further differentiate into mature 
monocytes. After about 8h monocytes extravasate into tissues where they 
subsequently differentiate into tissue specific macrophages. Granulocytes, 
monocytes and macrophages express αMβ2 integrin (Mac-1).  
Megakaryocyts mature within the BM and give rise to platelets, which are 
essential for blood clotting. Cells committed to the erythroid lineage develop to 
erythroid precursors and mature to erythroblasts, which give rise to erythrocytes. 
During their entire course of development, erythroid cells express the Ter119 (Ly-
76) antigen, which is not detectable on HSC or any other lineages. Additionally, 
erythroblasts express CD71 (transferrin receptor), which allows, together with 
Ter119, a more detailed distinction of developmental stages (Fig. 10). The most 
immature erythroid cells express medium levels of both of these markers before 
CD71 expression becomes up regulated. These Ter119 medium CD71 high cells 
mature into CD71 high Ter119 high cells. During further development the Ter119 
expression levels remain the same, while CD71 decreases until it is absent on 
mature erythrocytes. Ter119 medium, CD71 medium erythroid cells are erythroid 
progenitors that can be detected in a erythroid colony formation assay and have 
the potential for massive expansion, for example after acute erythrolysis 
(Socolovsky et al., 2001). 
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Figure 10: Different developmental stages of erythroid cells can be distinguished by their 
Ter119 – CD71 expression pattern.  
BM cells stained for Ter119 and CD71 allow the distinction of different sequential 
developmental stages of erythroid cells (1-5) as indicated in the dot plot. 
 
 
 
1.3 Role of β1 and β7 integrin in the hematopoietic system 
 
Integrins play an important role in the migration of hematopoietic cells during 
development, in the adult animal and under pathological conditions (Gonzales-
Amaro and Sanchez-Madrid, 1999). During the passage of leukocytes through the 
blood the integrins on the cell surface remain in a low affinity state in order not to 
make inappropriate interactions with ligands normally present in the blood or on 
endothelial cells. Leukocytes can loosely attach to the endothelium via selectins, 
which results in their rolling on the vessel wall. In the presence of chemokines, 
which are secreted constitutively in lymphoid organs or during inflammation, 
leukocytes with the corresponding chemokine receptors quickly upregulate 
integrin affinity leading to firm adhesion of leukocytes to the endothelium. 
Subsequently, the leukocytes cross the endothelial layer and the underlying 
basement membrane and migrate within the extravascular tissue. Although β1 
integrins are crucial for the extravasation of HSC, their role in extravasation of 
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differentiated blood cells is less clear. Using β1-null chimeric mice it was shown 
that β1 integrin is not required for the generation of HSCs/HPCs in the PAS/AGM 
region and in the YS, but that it is crucial for the colonization of the fetal liver in 
vivo (Hirsch et al., 1996). Fetal β1-null HSC are not able to exit the blood stream, 
most probably due to a defective adhesion to the endothelial cells (Potocnik et al., 
2000). However, they are able to survive and differentiate in liver and thymus 
organ cultures in vitro and in spleen in vivo indicating that the loss of β1 integrin 
does not affect the differentiation potential. Similarly, adult β1-null HSC can 
neither home to the BM nor migrate to other lymphoid organs. It was shown that 
adult β1-null HPC have a severely impaired adhesion to endothelial cells, 
suggesting that β1 integrin-mediated adhesion might be essential for all 
extravasation processes of HSC and HPC (Potocnik et al., 2000). Although 
antibody inhibition experiments suggested an important role of α4β1 integrin for 
the migration of adult HPC to the spleen (Williams et al., 1991), deletion of the 
α4 integrin gene did not interfere with the homing of HSC to the fetal liver or the 
BM (Arroyo et al., 1999). Also targeted disruptions of other β1 integrin associated 
subunits such as α3, α5 and α6, which are all expressed on HSC, did not impair 
BM homing, suggesting either the involvement of a yet unknown subunit binding 
to β1 or redundant function of various β1 integrins (Arroyo et al., 2000).  
For the retention within the BM, HSC need to adhere to stroma cells and to the 
extracellular matrix. In vitro assays suggested that this adhesion also controls 
survival, proliferation and differentiation of HSC and HPC (Papayanopoulou and 
Nakamoto, 1993; Coulombel et al., 1997). Agents like granulocyte-colony 
stimulating factor (G-CSF), granulocyte macrophage-colony stimulating factor 
(GM-CSF) or α4 integrin antibodies (Papayanopoulou et al., 1995) can mobilize 
hematopoietic cells resulting in an increased number of colony-forming units in 
the peripheral blood. How these substances interfere with the attachment of HSC 
and HPC to the BM stroma, however, is not clear. 
Within the BM, integrins are supposed to mediate the attachment of HSC to 
stroma cells and ECM, especially to fibronectin (Williams et al., 1991). This 
hypothesis, based on antibody inhibition experiments, was strengthened by the 
mobilization of HPC from the BM after injection of antibodies against α4 
integrin, recognizing α4β1 and α4β7 integrin, and with antibodies against 
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VCAM-1 or fibronectin fragments, both ligands of α4β1 and α4β7 
(Papayanopoulou et a., 1995; van der Loo et al., 1998). In vitro and in vivo α4β1-
mediated attachment of HPCs to FN promotes proliferation (Yokota et al., 1998; 
Schoefield, 1998) and prevents apoptosis (Wang et al., 1998). However, the 
induced deletion of β1 integrin in adult mice did not lead to increased release of 
HPCs into the periphery indicating that β1 integrin is not essential for the 
retention of HSCs/HPCs in the BM (Brakebusch et al., 2002). 
Colonisation of Peyer's patches (PP), a lymphoid tissue of the gut, is dependent on 
the presence of α4β7 on leukocytes and MAdCAM on the endothelial cells in the 
intestine (Wagner et al., 1996; Pabst et al., 2000). Neither α4-null nor β7-null 
lymphocytes could home to PP in vivo (Arroyo et al., 1996; Wagner et al., 1996). 
Since αEβ7 is expressed only on few lymphocytes others than IELs it was 
concluded that α4β7 is essential for the seeding of PP. In chronic inflammation, 
α4β1 integrin mediates extravasation of lymphocytes into the affected tissues 
(Yang et al., 2003). For the extravasation of neutrophils, β2 integrin is of major 
importance. Patients lacking a functional β2 integrin show severe 
immunodeficiencies and virtual absence of granulocytes in extra vascular tissues 
(Roos et al., 2001). On the other hand, β2 integrin-deficient mice do show some 
extravasation of neutrophils, suggesting that other molecules can also mediate the 
firm adhesion of these cells to the endothelium of inflamed tissues (Scharffetter-
Kochanek et al., 1998). Potential candidates for this function are β1 integrins. In 
line with this hypothesis is that α9β1 is highly expressed on granulocytes and 
contributes to the transendothelial migration of neutrophils in vitro (Taooka et al., 
1999).  
Antibody inhibitions experiments suggested that lymphocyte development in adult 
BM depends upon α4β1 integrin mediated adhesive interactions between 
hematopoietic cells and stroma cells (Miyake et al., 1991). The analysis of α4-null 
somatic chimeric mice, which in all tissues have different contributions of α4 
deficient cells, confirmed this observation. In the absence of α4 integrin, B cell 
development stopped before the pro-B cell stage. Furthermore, adult T cell 
progenitors could not emigrate from the bone marrow resulting in severe thymus 
atrophy after birth (Arroyo et al., 1996). Injection of α4-deficient BM cells into 
the blood, however, resulted in thymus colonization and generation of CD4+ and 
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CD8+ T cells, indicating that α4 integrin is not crucial for thymus colonization 
and T cell differentiation per se. Mice with a complete or restricted deletion of the 
VCAM-1 gene showed normal hematopoiesis, indicating that interaction of α4β1 
or α4β7 with VCAM-1 is not essential for lymphopoiesis (Leuker et al., 2001, 
Koni et al., 2001, Friedrich et al., 1996). 
The loss of α4 integrin also affects erythro- and myelopoiesis. In adult α4-null 
chimeric mice no erythrocytes derived from α4-null HSC could be detected. 
Furthermore, the number of monocytes and granulocytes was severely reduced 
due to a decreased expansion on the level of the progenitor cells. As an 
explanation for the impaired differentiation of α4-null HPC it was proposed that 
α4 integrin is crucial for the migration of progenitor cells through the BM stroma, 
which is considered to be necessary for the development in vivo (Arroyo et al., 
1996). However, no similar defects were observed in mice lacking VCAM-1, a 
major ligand of α4β1 integrin (Leuker et al., 2001). 
α4 integrin can dimerize with β1 and with β7 integrin. Since mice lacking β7 
integrin demonstrated normal hematopoiesis (Wagner et al., 1996), it was 
assumed that the loss of α4β1 is responsible for the impaired hematopoiesis. This 
predominant role of α4β1 integrin for adult hematopoiesis was tested recently 
using β1 mutant BM chimeric mice (Brakebusch et al., 2002). Surprisingly 
hematopoiesis was normal in these mice questioning the requirement of α4β1 
integrin in adult hematopoiesis. Two explanations could account for this 
unexpected result. First, the role of α4 integrin was studied in somatic chimeric 
mice and the deletion of the α4 gene was therefore not restricted to cells of the 
hematopoietic system. A deletion of the α4 integrin gene on other cells types, in 
particular BM stroma cells might have an impact on hematopoietic development. 
Second, α4β1 and α4β7 integrins might have redundant functions in early 
hematopoiesis so that only the absence of both molecules impairs hematopoiesis. 
This hypothesis was tested in this work by generating β1β7 mutant BM chimeric 
mice. These animals lack β1 and β7 integrin expression restricted to the 
hematopoietic system. Since the α4 subunit can only dimerize with β1 and β7 
integrin, we expected an indirect loss of α4 integrin from the cell surface 
equivalent to a knockout of the α4 integrin gene.  
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1.4 Aim of the project 
 
Based on published evidences of α4 somatic chimeric mice, α4β1 and α4β7 
integrin are indispensable for normal hematopoiesis. Since β7 knockout mice and 
β1 mutant BM chimeras had normal hematopoiesis, it was concluded that only 
simultaneous loss of α4β1 and α4β7 integrin as in α4-null chimeric mice, results 
in hematopoietic defects. This PhD project aimed to test this hypothesis. 
β1β7 mutant BM chimeras, in which both α4β1 and α4β7 integrin are absent 
were generated and analysed. The analysis focused on hematopoietic stem and 
precursor cell maintenance and function as well as on the development of 
different blood cell lineages. During the analysis a conditional knockout of α4 
integrin in the hematopoietic system focusing on HPC distribution was published 
giving this project the further aim of investigating the reason for conflicting 
results. 
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2. Materials and Methods 
 
 
 
2.1 Generation of mice with a deletion of the β1 and the β7 
integrin genes in the hematopoietic system 
 
Mice carrying a β1 integrin gene flanked by loxP sites (fl/fl) (Brakebusch et al., 
2002) were mated with mice with a neomycin-disrupted β1 integrin gene (+/-) 
(Fässler and Meyer, 1995), mice lacking a functional β7 integrin gene (β7-/-) 
(Wagner et al., 1996) and with mice expressing the cre recombinase under the 
control of the (polyinosinic-polycytidylic acid) polyIC-inducible Mx-promotor 
(+Mx) (Kühn et al., 1995). The Mx-promotor is silent in healthy mice but can be 
transiently activated upon application of Interferon α (IFN-α) or IFN-β or of 
synthetic double stranded RNA (polyIC) which induces IFNs. 
As a result mice were obtained carrying one conditional and one null allele for the 
β1 integrin gene, a constitutive deletion of both β7 integrin alleles and a transgene 
for the cre recombinase controlled by the Mx-promotor (β1β7 mutant: β1 (fl/-) β7 
(-/-) +Mx), β1 (fl/fl) β7 (-/-) +Mx). β7 null mice with a conditional and a wt allele 
for β1 and transgenic for the cre transgene (β1(fl/+) β7(-/-) +Mx) or with two 
conditional alleles for β1 without the cre recombinase (β1 (fl/fl) β7(-/-)) served as 
control animals (β7 mutant). Since the polyIC stimulated Mx-promoter is not only 
active in the hematopoietic system but also in various other tissues, we 
transplanted bone marrow (BM) from β7 mutant and β1β7 double mutant mice 
before knockout induction into lethally irradiated normal recipient mice, to restrict 
the gene deletion to the hematopoietic system. BM cells were isolated from 
femurs of (β1 (fl/-) β7 (-/-) +Mx or β1 (fl/fl) β7 (-/-) +Mx) and (β1 (fl/+) β7 (-/-) 
+Mx or β1 fl/fl β7 (-/-)) donor mice. BM chimeras were generated by tail vein 
injection of 106 bone marrow cells into lethally irradiated (6 MV X-rays, 10 Gy, 
6.2/min) B6.SJL recipient mice. Donor cells expressed the surface marker Ly5.2 
while host cells expressed Ly5.1, allowing a simple distinction by FACS analysis. 
After reconstitution of the hematopoietic system, 4-8 weeks after BM transfer, the 
2. Materials and Methods 21
deletion of the β1 integrin gene was induced by three intraperitoneal injections of 
250µg polyIC at two day intervals obtaining β1β7 mutant BM chimeras and β7 
mutant BM chimeras.  
Mice lacking β1 and β2 integrins in the hematopoietic system were obtained by 
intercrossing β1 (fl/fl) +Mx mice with mice carrying a constitutive gene deletion 
for β2 integrin (Scharffetter-Kochanek, K. et al., 1998) and subsequent polyIC 
treatment.  
 
 
 
2.2 Genotyping of β1, β2 and β7 mutant mice 
 
Mice were earmarked and genomic DNA was isolated at 2-3 weeks of age by 
digesting tail pieces in buffer containing 0.2% SDS, 100 mM Tris-HCL, pH 8.0, 
200 mM NaCl, 5 mM EDTA, pH 8.0 and 100 µg/ml proteinase K at 55°C over 
night. DNA was isolated the next day using a phenol-chlorophorm extraction and 
isopropanol precipitation according to Sambrook and Russell 2001. β1 conditional 
and wild type allele were distinguished using the primers 5´- AGG TGC CCT 
TCC CTC TAG A – 3´ and 5´- GTG AAG TAG GTG AAA GGT AAC – 3´. A 
touchdown program was run with 10 cycles starting from 63°C to 53°C annealing 
temperature, decreasing 1°C each cycle, and subsequent 35 cycles at 53°C 
annealing for 30s, 30s denaturing at 94°C and 30s elongation at 72°C each cycle. 
This reaction gave rise to a 345 bp product for the wild type allele and a 450bp 
product for the conditional allele. The β1 integrin null allele was amplified with 
the primers 5´- AGG TGC CCT TCC CTC TAG A – 3´ and 5´- TAA AAA GAC 
AGA ATA AAA CGC AC – 3´ amplifying a 210 bp fragment. The β7 integrin 
wild type allele was detected applying a similar touchdown program starting with 
10 cycles from 65°C to 55°C decreasing 1°C each cycle and subsequent 35 cycles 
at 55°C for 30s each cycle using the primers 5´- GAC CAG TGC CTA GGC TGC 
– 3´ and 5´- CCT CTA CTC CCG TCG GTC - 3´. If the DNA contained a 
functional β7 integrin gene a 600 bp band was obtained. The presence or absence 
of the cre-transgene was assessed by using the primers 5´- TTC GGA TCA TCA 
GCT ACA CC -3´ and 5´- AAC ATG CTT CAT CGT CGG – 3´ applying the 
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same program described for the detection of the β1 integrin wild type or 
conditional allele above. DNA from mice carrying the cre transgene gave rise to a 
419 bp fragment. The primers 5´- GCC CAC ACT CAC TGC TGC TTG – 3´ and 
5´- CCC GGC AAC TGC TGA CTT TGT – 3´ were used to amplify a 467 bp 
fragment for β2 integrin wild type mice and the latter one combined with the 
primer 5´- AGG ACA GCA AGG GGG AGG ATT -3´ giving rise to a 140 bp 
fragment. The same touchdown program used for the detection of the cre-
transgene was used for the genotyping of β2 integrin knockout allele. PCRs for all 
of these reactions was conducted in 20 µl reaction volume containing 2 µl purified 
genomic DNA and a mastermix of the following components listed for one 
reaction: 0.2 µl 100 pmol/µl of primer I and II, 0.4 µl 10 mM dNTPs, 2 µl 
10xPCR buffer, 0.8 µl 50 mM MgCl, 0.08 µl 5 U/µl Taq-polymerase and 14.32 µl 
H2O using a Biometra® Thermocycler. Recombinant Taq-polymerase, MgCl and 
10xPCR buffer was purchased from InvitrogenTM. All reactions were 
electrophoretically separated on a 2% agarose gel containing 0.5 µg/ml ethidium 
bromide and photographed on a UV-table. 
 
 
 
2.3 Animal treatment 
 
Mice were bred and housed in compliance with the German Law for Welfare of 
Laboratory Animals. All animal experiments were approved by the local ethic 
committee. Blood samples were obtained from the retro-orbital plexus under 
anaesthesia using the inhalation anaesthetic IsoFlovet ® form Schering-Plough 
Animal Health. Acute haemolysis was assessed after two daily intraperitoneal 
injections of 60 mg phenylhydrazine (PHZ; Sigma) per kg mouse weight at day 1 
and 2. Mice were scarified for analysis at day 4. Animals were scarified by 
cervical dislocation. 
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2.4 Türk staining 
 
Whole blood of β7 mutant and β1β7 mutant BM chimeras was isolated, diluted 
1:10 with Türk stain (0.01% of methilrosaniline chloride and 1.0% acetic acid) 
and differentially counted for polymorphonuclear and mononuclear cells in a 
haemacytometer. 
 
 
 
2.5 Flow cytometry 
 
Single cell suspensions were prepared by gently pushing the dissected organs 
through 70 µm cell strainers (Becton Dickinson) in a Petri dish. Cells were then 
transferred into a 50 ml Falcon tube and washed in 20 ml FACS-buffer (1% 
bovine saline albumin (BSA) in phosphate buffered saline (PBS 8.4 mM 
Na2HPO4, 1.5 mM NaH2PO4, 137 mM KCl, pH 7.4). After subsequent 
centrifugation at 1300 rpm at 4°C the cells were resuspended in 10ml FACS-
buffer and counted in a haemacytometer. For phenotype analysis, 1x106 cells from 
bone marrow (BM), spleen and lymph nodes (LN) were incubated with 
fluorescently labelled antibodies in 50µl antibody solution for 30 min at 4°C in 
the dark. Erythrocytes in blood samples were lysed using ACK-buffer (0.15 M 
NH4Cl, 1 mM KHCO3, and 0.1 mM Na2EDTA) before staining (Coligan et al., 
1995).  
The following primary antibodies were used in flow cytometry: hamster anti-β1 
integrin (Ha2/5), rat anti- β7 integrin (M293), rat anti-α4 integrin (R1-2, 9C10, 
5/3 and PS/2), rat anti-B220 (RA3-6B2), rat anti-CD19 (1D3), rat anti-IgM (R6-
60.2), rat anti-IgD (11-26c.2a), rat anti-CD4 (H129.19), rat anti-CD8 (53-6.2), rat 
anti-CD3 (17A2), rat anti-Gr-1 (RB6-8C5), rat anti-Mac-1 (M1-70), rat anti CD71 
(C2), rat anti Ter-119 (Ter119), mouse anti-Nk1.1 (PK136), rat anti sca-1 (D7), 
rat anti c-kit (2B8) rat anti-Ly-5.1 (A20), rat anti-Ly-5.2 (104) (all Pharmingen, 
USA). Primary antibodies were conjugated with FITC (Fluorescein), PE 
(Phycoerythrine) or biotin and used at 1:200 dilutions in FACS-buffer to block 
unspecific binding. After washing the cells with 200 µl FACS-buffer they were 
incubated in 50 µl secondary antibody solution for 30 min or fluorescently 
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labelled streptavidin for 10 min at 4°C in the dark, washed again and analysed by 
FACS. Biotinylatyed antibodies were detected by streptavidin PE (Southern 
Biotechnology, 1:2000 dilution) or streptavidin Cy-5 (Jackson Immunoresearch, 
1:500 dilution). Rat anti-α4 integrin 5/3 and PS/2 were detected with donkey anti 
rat Cy5 as a secondary antibody (Jackson Immunoresearch, 1:500 dilution). Dead 
cells were excluded from the analysis by propidium iodide (1 µg/ml) 
counterstaining. Erythrocytes and debris were excluded by FSC/SSC gating. 
In all dot plot analyses shown the percentage of cells in the respective quadrant is 
indicated. The cells in the lower left quadrant show no staining significantly 
distinct from the autofluorescence of these cells. For the analysis of platelets 5µl 
antibody solution containing β1 integrin antibody (Ha2/5) FITC-labelled and 
GPIb-IX (p0p1) PE-labelled (a gift from B. Nieswandt) both diluted 1:10 in PBS 
was added to 1µl whole blood. After 15 min incubation at room temperature in the 
dark 100 µl PBS was added and samples were analysed by FACS. 
 
 
 
2.6 Colony formation assay 
 
For colony formation assays leukocytes were suspended in 300 µl Iscove's 
modified Dulbecco’s medium (IMDM) with 2% FCS in a 15 ml tube and mixed 
with 3 ml methylcellulose supplemented with growth factors and cytokines and 
plated into three wells of a 6 well plate after dissipation of air bubbles.  
For colony assays detecting granulocyte/monocyte precursors 180.000 BM cells, 
3.600.000 splenocytes or 250 µl whole blood were added to 3 ml MethoCult GF 
M3534 (StemCell Technologies, Vancouver, Canada), containing erythropoethin 
(Epo), interleukin-3 (IL-3), IL-6, and stem cell factor (SCF). In blood samples 
erythrocytes were lysed by incubation in ACK-lysis buffer for 5 min at room 
temperature prior to culture. For pre-B cell colony assays 800.000 BM cells were 
mixed with MethoCult M3630 (StemCell Technologies) containing IL-7. To 
measure the amount of erythroid colony forming units (CFUe) 600.000 BM cells 
or 1.200.000 splenocytes were mixed with 3 ml Methocult M3334 (StemCell 
Technologies) containing 10 µg/ml Insulin, 200 µg/ml iron saturated human 
transferrin and 3 units/ml Epo were plated into three wells of a 6 well plate. To 
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prevent the cultures from drying out the interspaces of the 6 well plates were filled 
with PBS. GM and pre-B colonies were counted after 7 days of incubation at 
37°C, 5% CO2 under a dissection microscope. For FACS analysis colonies were 
picked into a 96 well plate with 100 µl PBS in each well, centrifuged and stained 
with β1 integrin and Gr-1 antibody for GM colonies and β1 integrin and B220 
antibody for pre-B colonies, washed, resuspended in 100µl PBS and analysed by 
FACS. CFUe colonies were stained with benzidine (Sigma, B3503) after 3 days of 
incubation at 37°C, 5% CO2. For staining, benzidine was dissolved in 12% acetic 
acid and immediately before usage complemented with H2O2 to a final 
concentration of 0.3%. 1 ml staining solution was added to each well of a 6 well 
plate. Haemoglobinized colonies turned dark blue and were counted under a 
dissection microscope. 
CFUe colonies were then picked into PCR tubes containing 100 µl PBS and 
centrifuged for 5 min at 1400 rpm at 4°C. The supernatant was discarded and the 
cells were subsequently incubated in 5 µl alkaline lysis solution (0.2 M KOH, 
0.05 M Dithiothreitol (DTT)) for 10 min. After addition of 5 µl of neutralisation 
solution (0.9 M Tris pH 8.3, 0.3 M KCl, 0.2 M HCl) genomic DNA was subjected 
to a random preamplification as described by Lin Zhang et al., (1992). In brief, 
each PCR reaction was performed in a total volume of 50 µl containing 20 µl 
random 15-mere 100 pmol/µl primers, 0.6 µl 10 mM dNTPs, 6 µl of a solution 
containing 0.025 M MgCl, 0.1% gelatine, 0.1 M TrisHCl pH 8.3, 1 µl Taq 
polymerase purchased from InvitrogenTM and 20.4 µl H2O. The random 
preamplification PCR program includes 50 primer extension cycles. Each cycle 
consists of a denaturation step at 92°C of 1 min, an annealing step at 37°C of 2 
min and an extension step of 4 min at 55°C. After random preamplification of the 
genomic DNA 6 µl of each sample of this reaction was genotyped by genomic 
PCR in a 20 µl PCR reaction as described above.  
 
 
 
2.7 Separation of splenocytes by MACS 
 
Single cell suspension from the spleen was prepared by gently pushing the 
dissected organ through a 70 µm cell strainer (Becton Dickinson) in a Petri dish. 
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The cells were transferred into a 50 ml Falcon tube and washed in MACS-buffer 
(0.5% BSA, 2 mM EDTA in PBS). Splenocytes from a whole spleen were divided 
into three fractions and stained with B220, CD4 and CD8 antibodies (all FITC 
labelled), respectively as described for FACS analysis. Magnetic sorting was 
carried out with MACS beads according to the manufacturer’s instructions 
(Miltenyi biotec). Briefly, for usage of anti-FITC microbeads FITC labelled cells 
were resuspended in 90 µl MACS-buffer per 1x107 cells and 10 µl MACS anti 
FITC-microbeads were added. After 15 min incubation at 4°C the cells were 
washed with 2 ml MACS-buffer and centrifuged at 300 g for 10 min. After 
resuspending cells in 500 µl MACS-buffer cells were applied to a MiniMACS 
separation column attached to the MiniMACS separation unit (magnet) 
equilibrated with 500 µl MACS-buffer and placed at the MACS Multistand. The 
column was washed three times with 500 µl buffer to remove all unlabelled cells. 
Then the MACS column was removed from the magnet and placed on a collection 
tube. To elute all cells 1 ml buffer was applied to the column and firmly flushed 
out using the plunger supplied with the column. Since the eluted cells were FITC 
labelled the purity of the sort was checked subsequently by FACS. 
 
 
 
2.8 Southern blot analysis 
 
Genomic DNA was isolated from BM, spleen and thymus single cell suspensions 
using proteinase K digestion, phenol-chloroform extraction and isopropanol 
precipitation as described above (3.2). Southern blotting was performed according 
to standard procedures (Sambrook and Russell, 2001). DNA was digested with 
EcoRI and probed with a fragment of the lacZ gene, which detects only the 
targeted allele. Membranes were exposed to X-ray films and the resulting bands 
quantified using Bio-PROFIL Bio-1D V97.03 software (Vilber-Lourmat©). 
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2.9 Iodination of cell surface proteins and subsequent 
immunoprecipitation and gel electrophoresis 
 
BM cells were washed with PBS in a polystyrene tube and cell surface proteins 
labelled with 125I using the lactoperoxidase method as described previously (Lang 
et al., 1987). In brief, 5x107 BM cells were resuspended in 0.5 ml PBS pH 6. 
Under continuous stirring 5.7 µl lactoperoxidase 88 U/ml, 1 mCi 125I (Amersham) 
and 25 µl H2O2 (diluted immediate before use 1:1000) were added. After 5 min 
additional 2.8 µl LPO and 12 µl H2O2 were added and incubated under stirring for 
5 more minutes. The iodination reaction was terminated by adding 0.5 ml solution 
containing 1mM DTT and 1 mg/ml tyrosine. Cells were washed twice and then 
lysed for 30 min in 2 ml lysis buffer (50 mM Tris-HCL, pH 7.4, containing 0.15 
M NaCl, 3 mM MgCl2, 1 mM CaCl2, 1%Triton X-100) containing proteinase 
inhibitors (Fässler et al., 1995). After centrifugation at 10.000 g for 15 min the 
supernatant was transferred to a new tube. Then the lysate was precleared with 30 
µl Protein-G beads for 1 hour at 4°C and an immunoprecipitation (IP) was 
performed using anti α4 integrin monoclonal antibody (clone 5/3) and anti αM 
integrin antibody (clone M1/70) according to Zeller et al., 1998. The supernatant 
and the precipitates were resuspended and heated in 20 µl – 50 µl Laemmli buffer 
containing β-mercaptoethanol at 95°C for 5 min and separated on a 6% SDS 
polyacrylamide gel. To estimate protein sizes the protein molecular weight 
markers were run in a separate lane (Broad range BioRad®). The protein was 
transferred onto a Nitrocellulose membrane (Protran® from Schleicher & Schuell) 
by Western blotting in transblot-buffer containing 48 mM Tris-HCl, 39 mM 
glycin, 0.03% w/v SDS and 20% methanol in water. To visualise the protein 
weight marker the membrane was first washed 3 times in water for 5 min each 
and then stained in 1% (v/v) Ponceau S (Sigma) in H2O for 30 s to 1 min and 
subsequent destained in water until bands appear on the membrane. After the 
bands of the protein weight standard were recorded by photocopy the residual 
Ponceau S stain was extracted from the protein bands with several washes with 
water. Without drying out the membrane at any point it was then enwrapped in 
foil and exposed to X-ray sensitive film. 
For paxillin immunodetection blots were blocked in 5% non-fat dry milk/TBS pH 
7.5/0.1%Tween20 (blocking solution) for 1 h at RT and probed with monoclonal 
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anti paxillin antibody in blocking solution for 1 h at RT or 4oC overnight. Blots 
were then washed with blocking solution 6 times for 5 min each and incubated 
with the secondary horseradish peroxidase-labelled antibody diluted in blocking 
solution for 1 h at RT. The blots were washed with TBS 5 min 5 times and signal 
was detected with ECL+PlusTM kit (Amersham Pharmacia). 
 
 
 
2.10 Soluble VCAM-1 binding assay  
 
The binding to VCAM-1 was tested by incubating 400,000 BM cells in 50 µl with 
soluble VCAM-1 (Makarem et al., 1994) labelled with oregon green (kindly 
provided by M. Humphries University of Manchester, UK) in Tris buffered saline 
(TBS) (150 mM NaCl, 10 µM Tris-HCL, pH 7.4) at room temperature. To 
activate integrin heterodimers, incubation and washing steps were carried out in 
the presence of 1 mM MnCl2. Integrin independent binding was assessed in the 
presence of 2 mM EDTA. After 15 min incubation 50 µl β1 and α4 integrin 
antibody solution diluted 1:100 was added and incubated 15 more minutes. Cells 
were washed in the presence of 1 mM MnCl2 and 2 mM EDTA respectively and 
analysed by FACS. 
 
 
 
2.11 Generation of a cell line deficient for β1, β2 and β7 integrins 
 
To generate a fibroblastoid cell line deficient for β1, β2 and β7 integrin, mice 
conditional for β1 integrin, positive for the cre-transgene and deficient for β7 
integrin were crossed with animals lacking a functional β2 integrin gene. The 
offspring of this mating were intercrossed and the pregnant mice sacrificed at day 
13.5 counting the day of the plug as day 0.5. The embryos were prepared 
aseptically, the head and inner organs removed and the remaining material cut 
into small pieces. After incubation in 1xtrypsin/EDTA for 10 min at 37°C and 
breaking tissue pieces by pipetting up and down the material was taken up in 
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DMEM medium containing 10% fetal bovine serum (FBS) and seeded into a 
tissue culture flask. For immortalisation culture medium of 865-SV40 largeT cells 
encoding retrovirus that can transduce the SV40 large T antigen into murine cells 
was centrifuged and filtered with a celluloseacetate membrane pore size 0.2µm 
(Renner GmbH Darmstadt/Germany). Together with polybrene at final 
concentration of 8 µg/ml, the virus containing supernatant was added to the cells 
to be immortalized. 12h later the medium was exchanged for EF medium and the 
cells were expanded and cloned by limiting dilution. Two isolated (β2(-/-)β7(-/-) 
β1(fl/fl) clones were infected with an adenovirus carrying the cre recombinase. 
The cre-mediated deletion of the β1 integrin gene was confirmed on isolated 
clones by FACS analysis. 
 
 
 
2.12 Reverse transcription polymerase chain reaction (RT-PCR) 
 
For transcription analysis total RNA was prepared using TRIZOL® Reagent 
according to the manufacturer’s instructions (Invitrogen). RNA was reverse 
transcribed with SuperscriptTM III reverse transcriptase (Invitrogen) using gene 
specific primers. For β7 integrin the primer 5´- GCT TGA AGA GTG ACC CAG 
AAA TCC - 3´ was used. The primer anneals to two different exons in order not 
to obtain any PCR products from contaminations of genomic DNA. For first 
strand synthesis 1 µg total RNA, 2 pmol of the gene specific primer, 1µl 10mM 
dNTPs and 10 µl H2O were mixed and heated to 65°C for 5 min and then 
incubated on ice. Each sample was then complemented with 4 µl 5x first strand 
buffer (Invitrogen), 1 µl 0.1 M DTT and 1 µl Superscript reverse transcriptase and 
incubated at 55°C for 1h for synthesis. The reaction was inactivated by heating at 
70°C for 15 min. In PCR detecting β7 integrin the primers 5´- GCT TGA AGA 
GTG ACC CAG AAA TCC - 3´ and 5´- AGC AAT GGT GTC TAC ACG AAC 
AGC – 3´ resulted in a 392bp product.  
As an internal standard, expression of glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH), a cellular housekeeping gene, was analyzed using the primers 5’- GGT 
GAA GGT CGG AGT CAA CGG ATT TGG TCG – 3´ and 5’-GGA TCT CGC 
TCC TGG AAG ATG GTG ATG GG-3’ resulting in a 520bp product. The PCR 
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reaction was carried out in a 50 µl volume using 2 µl cDNA from the first strand 
reaction according to the manufacturer’s instructions. The resulting DNA products 
were separated by 2% agarose gel electrophoresis containing 0.5 µg/ml ethidium 
bromide and photographed. 
 
 
 
2.13 Transformation of fibroblastoid cells with α4 integrin cDNA 
 
To express α4 integrin in fibroblastoid cells, target cells were infected with a 
retrovirus encoding α4 integrin cDNA (Gosslar et al., 1996). The cell line (GP+E-
86) continuously producing this virus was kindly provided by B. Holzmann 
(Technical University Munich). In brief, subconfluent GP+E-86 cells were grown 
over night in fresh EF medium. The next morning the medium was collected, 
centrifuged and filtered with a cellulose acetate membrane pore size 0.2 µm 
(Renner GmbH Germany). This medium was complemented with polybrene to a 
final concentration of 8µg/ml and added to the target cells that were 50% - 80% 
confluent. After approximately 12h the medium was exchanged for fresh EF 
medium. The expression of α4 integrin was analysed by FACS analysis. 
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3. Results 
 
 
 
3.1 Generation of mice with a deletion of the β1 and β7 integrin 
genes in the hematopoietic system 
 
To test whether α4β1 and α4β7 have redundant functions mice were generated 
lacking both receptors in the hematopoietic system. 
To achieve this goal, mice carrying a conditional knockout for β1 integrin, a β1-
null allele and a cre recombinase transgene under the control of the polyIC 
inducible Mx-promotor were intercrossed with mice lacking a functional β7 
integrin gene (Wagner et al.,, 1996). Thus, mice were obtained, which are 
deficient for β7 integrin and carry an inducible β1-null gene (β1 (fl/-) β7 (-/-) Mx-
cre+ or β1 (fl/fl) β7 (-/-) Mx-cre+)  and, as controls, mice, which are deficient of 
β7, but constitutively express β1 (β1 (fl/+) β7 (-/-) Mx-cre+ or β1 (fl/fl) β7 (-/-)). 
Since the Mx-promotor is strongly active in HSC, but also in many non-
hematopoietic cells such as hepatocytes and endothelial cells, injection of polyIC 
into the conditional knockout mice would result in a loss of the β1 integrin gene in 
many tissues. To restrict the deletion to the hematopoietic system, BM from these 
mice was transplanted into lethally irradiated recipient mice after the complete 
repopulation of the hematopoietic system. The ablation of the conditional β1 gene 
was induced by three intraperitoneal injections of 250µg poly IC at two day 
intervals. The constitutive knockout of the β7 integrin gene was checked by 
genomic PCR of the BM donor mice and by FACS staining of cells derived from 
β7 integrin deficient BM chimeras in each experiment. In all analyses, no wild 
type β7 gene was detected (Fig. 11A). 
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Figure 11: Loss of β1 and β7 integrin expression in BM cells of β1β7 mutant mice 
A: PCR analysis of genomic DNA isolated from mouse tail showed no band for the β7 
integrin wild type allele in a β7-deficient mouse. 
B: Single cell suspensions from BM of wild type and β1β7 mutant mice were prepared 2 
months after polyIC injection, stained with antibodies against β1 and β7 integrin and 
analysed by FACS. No β7+ and only little residual β1+ cells were detected. 
 
FACS analysis confirmed the complete loss of β7 integrin expression, while in 
wild type mice approximately 18% of the cells express β7 integrin (Fig. 1B). 
Before knockout induction more than >85% of wild type BM cells expressed β1 
integrin. 2 months after polyIC injection less than 5% of BM cells of β1β7 mutant 
mice expressed β1 integrin as determined by FACS (Fig. 1B).  
To analyse the time course of the ablation of the β1 integrin gene we monitored 
the loss of β1 integrin expression on platelets, since platelets express high 
amounts of β1 integrin allowing a clear distinction of β1+ and β1- platelets. In 
addition, platelets and their precursors have a short life span of less than 2 weeks. 
A deletion of the β1 integrin gene on HSC is, therefore, quickly detected on 
β1 integrin 
1.4 16.4 0 0 
β7 integrin 
12.8 69.4 4.9 95
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platelets. At day 0 β7 mutant and β1β7 mutant BM chimeras received the first of 
three injections of polyIC and blood was taken from the retro-orbital plexus after 
2, 4, 7, 10, 14, 21 and 30 days. Platelets of these blood samples were checked for 
their β1 integrin expression. Two days after the first polyIC injection there were 
already β1 negative platelets detectable in β1β7 mutant BM chimeras (Fig. 12). In 
these mice the relative amount of β1 deficient platelets increased continuously to 
reach 93% after 14 days and 97% after 21 days and later. In β7 mutant mice, on 
the other hand, close to 0% of the β7 mutant platelets were β1 integrin negative at 
all time points. 
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Figure 12: β1 integrin expression on platelets is quickly reduced after knockout induction 
Percentages of β1 integrin negative platelets isolated from β7 mutant and β1β7 mutant 
BM chimeric mice are shown at indicated time points after the first of three polyIC 
injections (day 0). Error bars show the standard deviation. (n (β7 mutant BM 
chimera)/(β1β7 mutant BM chimera): 9/6).  
 
These data show that the deletion of the β1 integrin gene can be induced within a 
few days in a β7 mutant background. Furthermore, they confirm that the 
development of megakaryocytes and platelets is not crucially dependent on β1 and 
β7 integrin.  
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To test the deletion of the β1 integrin gene in different lymphoid organs, Southern 
blot analysis of BM, thymus and spleen of β1β7 mutant and β7 mutant BM 
chimeras was carried out 10 months after the transient induction of the β1 gene 
deletion (Fig. 13). 
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Figure 13: High efficiency of β1 integrin gene deletion in BM, thymus and spleen even 10 
months after induction of the β1 gene deletion 
DNA was isolated from single cell suspensions from BM, thymus and spleen from β1β7 
mutant BM chimeras 10 months after polyIC treatment. Southern blot analysis detecting 
the conditional and the null allele was performed (a representative result is shown on the 
right panel). Band intensities were quantified and visualized in a bar graph. Error bars 
show the standard deviation. (n (β7 mutant BM chimera)/(β1β7 mutant BM chimera): 
3/3).  
 
An efficient knockout of the β1 integrin gene was detected in BM, thymus and 
spleen 10 months after the knockout induction (Fig. 13). Since only HSCs can 
sustain hematopoiesis for more than 3 months, these data indicate that β1β7 
deficient HSCs are maintained in vivo. 
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3.2 Cellularity of lymphatic organs in the absence of β1 and β7 
integrin 
 
In order to investigate the development of different hematopoietic cells that derive 
from HSCs, we first checked the cellularity of different lymphoid organs. 
Lymphocyte migration to PP was reported to depend on β7 integrin (Wagner et 
al., 1996). As expected only small PP with severely decreased cellularity were 
found in β1β7 mutant BM chimeras. 
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Figure 14: Normal cellularity of lymphoid organs of β1β7 mutant BM  
Single cell suspensions from BM, thymus, spleen and lymph nodes (2 inguinal, 2 axial, 1 
para-aortic) from β7 mutant and β1β7 mutant BM chimeric mice 2 months after the gene 
deletion were made and cells counted using a haemacytometer. The bar graph shows the 
absolute cell number in the respective tissues. Error bars show the standard deviation. n 
(β7 mutant BM chimera)/(β1β7 mutant BM chimera): (4/4).  
 
Neither 2 months (Fig. 14), nor 10 to 12 months (data not shown) after induction 
of the gene deletion any differences were observed in the cellularity of BM, 
thymus or spleen of β7 mutant and β1β7 mutant BM chimeras, giving no 
evidence for defective hematopoiesis in the absence of β1 and β7 integrins. 
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3.3 Analysis of polymorphonuclear and mononuclear cells in the 
peripheral blood 
 
To determine the concentration of mononuclear (monocytes, lymphocytes) and 
polymorphonuclear (neutrophils) that are characterized by a lobed, fragmented 
nucleus, Türk staining of whole blood was conducted and cells counted using a 
haemacytometer. No significant differences were found comparing β7 mutant 
with β1β7 mutant mice (Fig. 15). 
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Figure 15: Normal concentrations of mononuclear and polymorphonuclear cells in the 
peripheral blood of β7 mutant and β1β7 mutant BM chimeras  
Whole blood was collected retro-orbitally from β7 mutant and β1β7 mutant BM chimeric 
mice 6 months after the gene deletion. The blood was diluted 1:10 with Türk stain and 
differentially counted in a haemacytometer. The bar graph shows the concentration of the 
respective cells in the blood. Error bars show the standard deviation. (n (β7 mutant BM 
chimera)/(β1β7 mutant BM chimera): 4/4).  
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3.4 Retention of HSCs and HPCs in the absence of β1 and β7 
integrin 
 
α4 integrins were shown to be crucial to retain HPCs within the BM as antibodies 
blocking α4 led to a release of precursors into the blood (Papayannopoulou et al., 
1995). In β1 mutant BM chimeric mice, however, HSCs were maintained in the 
BM and no increased release of HPCs was observed. To assess whether the 
simultaneous loss of β1 and β7 integrin reduces the amount of HSCs and HPCs in 
the BM, we determined the amount of lin- c-kit+ cells in the BM of β1β7 and β7 
mutant mice 10 months after knockout induction. No significant reduction of 
HSCs/HPCs was detected in the absence of β1 and β7 integrins, suggesting that 
α4 integrins are not crucial for the retention of HSCs/HPCs in the BM (Fig. 16). 
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Figure 16: No differences in the number of HSCs/HPCs in the BM between β7 mutant 
and β1β7 mutant BM chimeras 10 months after the induction of the β1 integrin gene 
deletion. 
Single cell suspensions were made from BM from β7 mutant and β1β7 mutant BM 
chimeras 10 months after the gene deletion and stained with a lineage cocktail containing 
the lineage markers B220, CD4, CD8, Mac-1, Gr-1, Nk1.1 and Ter119 and with c-kit. 
Cells derived from the host mice were excluded by a Ly5.1 counterstaining. The bar 
graph shows the relative amount of lineage negative, c-kit positive cells which should 
include all HSCs/HPCs. Error bars show the standard deviation. (n (β7 mutant BM 
chimera)/( β1β7 mutant BM chimera): 3/3).  
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3.5 Lymphopoiesis in the absence of β1 and β7 integrin 
 
3.5.1 B cell development in vitro 
 
Since previous studies suggested that B cell development was dependent on α4 
integrin (Arroyo et al., 1999), but neither on β1 integrins (Brakebusch et al., 
2002), nor on β7 integrins (Wagner et al., 1996) alone, we investigated whether 
β1 and β7 integrins have a redundant function in B cell development. To test for 
the development of pre B cells in the absence of β1 and β7 integrins in vitro, pre-
B-colony formation assays with BM cells were performed. Both β7 mutant BM as 
well as β1β7 mutant BM gave rise to pre-B colonies of similar morphology (Fig. 
17). 
 
 
 
 
  
 
 
 
 
  β1β7 mutant   β7 mutant  
Figure 17: Pre-B cells from β7 mutant and from β1β7 mutant BM form colonies that are 
morphologically similar. 
Single cell suspensions were made from BM from β7 mutant and β1β7 mutant BM 
chimeras 2 months after the gene deletion. 800000 BM cells were seeded into MethoCult 
M3630 medium and colonies were photographed (magnification 50x) 7 days later. 
 
FACS analysis of the colonies confirmed that β7 mutant colonies were β1 integrin 
positive, while most of the β1β7 mutant colonies did not express β1 integrin (Fig. 
18).  
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 A B 
BM  popul. size 
(n=4/4)  β7mutant  β1 β7mutant
     
B220med  5.2±1.6  5.5±1.2 
B220 hi  5.7±1.8  4.7±1.1 
CD19  12.9±6.2  10.5±2.5 
IgM  6.0±1.1  5.1±1.4 
IgD  8.5±6.5  4.7±1.1 
 
Spleen  popul. size 
(n=4/4)  β7mutant  β1 β7mutant
     
B220hi  40.5±12.0  37.7±12.8 
CD19  38.9±13.9  36.9±10.5 
IgM  34.6±3.5  32.8±9.3 
IgD  39.7±1.6  45.5±15.7 
 
 
 
 
 
 
 
Figure 19: Normal B cell population sizes 
in β1β7 mutant mice 
LN  popul. size 
(n=4/4)  β7mutant  β1 β7mutant
     
B220hi  19.8±4.0  18.3±4.5 
CD19  17.4±4.3  16.1±5.5 
IgM  8.4±3.7  9.0±3.5 
 IgD  15.0±1.7  16.7±7.0 
β1 integrin 
β1 integrin 
B220hi 
spleen 
B220med
BM 
β1 integrin 
A: Single cell suspensions from BM, spleen and LN of β7 mutant and β1β7 mutant BM 
chimeras 2 months after polyIC treatment were prepared, stained with antibodies against 
B220, CD19, IgM, IgD and against β1 integrin and analysed by FACS. The averages of 
the population sizes in the respective tissues are shown with standard deviations. (n (β7 
mutant BM chimera)/( β1β7 mutant BM chimera): 4/4).  
B: Representative histogram overlays show the β1 integrin expression of β7 mutant 
controls (filled) and of β1β7 mutant BM chimeras (line). The upper diagram visualizes 
the loss of β1 expression in β1β7 mutant on immature B cells in the BM (B220 medium 
cells), the lower one shows the difference in β1 expression for mature B cells in the 
spleen (B220 high). 
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B220 (pre-pro-B and later), CD19 (pro-B and later), IgM (immature B) and IgD 
(mature B). 2 months after knockout induction no significant differences were 
obtained between β7 and β1β7 mutant BM chimeras for the sizes of the 
populations characterised by these markers in any of these tissues investigated 
(Fig 19). All B cell subpopulations in β1β7 mutant BM chimeras showed a loss of 
β1 integrin expression as determined by FACS. This reduction was more obvious 
on B220medium cells, which express higher levels of β1 integrin than B220high 
cells. 
 
10 to 12 months after the knockout induction of the β1 integrin gene again B cell 
development was analysed in BM and spleen using the B cell lineage affiliated 
markers B220, CD19, IgM and IgD (Fig. 20). 
Also 10 to 12 months after the induction of the β1 integrin gene deletion, B cell 
development was rather normal, although a slight reduction of B220med cells was 
observed. In LN a small reduction in the number of B cells was detected. 
However, only 3 β7 mutant and 3 β1β7 mutant tissues were analysed. More mice 
have to be analysed to test the significance of these alteration. 
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 A B 
BM  popul. size 
(n=5/5)  β7mutant  β1 β7mutant
     
B220med  3.7±1.6     1.6±0.8 * 
B220 hi  7.8±3.9  9.7±7.6 
CD19  9.1±3.7  8.6±6.7 
IgM  4.3±1.7  6.6±3.6 
IgD  4.7±2.4  5.5±4.1 
β1 integrin 
B220med
BM 
 
spleen  popul. size 
(n=5/5)  β7mutant  β1 β7mutant
     
 
 
 
B220hi 
spleen 
B220hi  50.7±9.7  39.7±11.3 
CD19  48.6±11.6  40.7±8.4 
IgM  28.4±7.0  22.3±6.5 
IgD  36.7±9.6  28.9±4.8 
 
 
 
 
LN  popul. size 
(n=3/3)  β7mutant  β1 β7mutant
     
B220hi  57.9±2.8  38.9±11.0 *
CD19  58.4±2.5  39.9±11.1 *
IgM  20.3±6.1  11.3±4.0 * 
IgD  47.0±0.3  31.4±11.3 *
 
 
 
β1 integrin  
 
 
Figure 20: Normal B cell population sizes 
in β1β7 mutant mice 
A: Single cell suspensions from BM, spleen and LN of β7 mutant and β1β7 mutant BM 
chimeras 10 to 12 months after polyIC treatment were prepared, stained with antibodies 
against B220, CD19, IgM, IgD and against β1 integrin and analysed by FACS. The 
averages and standard deviation of the population sizes are shown in the tables for the 
respective tissues, asterisks indicate a significant difference according to student’s t test. 
(n (β7 mutant BM chimera)/( β1β7 mutant BM chimera): BM 5/5, spleen 5/5, LN 3/3).  
B: Representative histogram overlays show the β1 integrin expression of β7 mutant 
controls (filled) and the β1 expression of β1β7 mutant β1β7 BM chimeras (line). The 
upper diagram visualizes the loss of β1 expression in β1β7 mutant on immature B cells in 
the BM (B220 medium cells), the lower one shows the difference in β1 expression for 
mature B cells in the spleen (B220 high). 
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The low expression of β1 integrin on B220hi cells even in the β7 mutant control 
mice made it difficult to quantify the loss of β1 integrin in this subpopulation in 
β1β7 mutant mice using FACS. Therefore, we determined the knockout efficiency 
in B220+ B cells from spleen, purified by MACS beads, on genetic level using 
Southern blot (Fig.21). 
 
A B  
 
0
20
40
60
80
100
B220+
pe
rc
en
ta
ge
 o
f n
ul
l c
el
ls
B220+ splenocytes 
B220
 
 
 
 
 
 
 
 
 
 
 
Figure 21: B220+ B cells have an efficient deletion of the β1 integrin gene  
Single cell suspensions from spleen of β7 mutant and β1β7 mutant BM chimeras 6 
months after polyIC treatment were prepared, stained with B220-FITC antibody and 
subsequently sorted using anti FITC MACS beads.  
A: FACS analysis of the B220+ enriched fraction indicated higher than 95% purity 
(representative histogram is shown) 
B: DNA was prepared from MACS-enriched B220+ splenocytes, Southern blot 
performed and densitrometically evaluated. The bar graph shows the relative 
amount of B220+ cells deficient for a functional β1 integrin gene. Error bar shows 
the standard deviation. (n (β7 mutant BM chimera)/( β1β7 mutant BM chimera): 
5/5).  
 
These data indicate that in the absence of β1 and β7 integrins B cells can fully 
mature and migrate to spleen, LN and, as B220hi cells, from the periphery back to 
the BM. 
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3.5.3 T cell development in the absence of β1 and β7 integrins 
 
T cell precursors originate from the BM and migrate to the thymus. In the thymus 
they differentiate from thymocytes that lack CD4 and CD8 (double negative 
(DN)) via thymocytes that express both CD4 and CD8 (double positive (DP)) into 
mature T cells expressing either CD4 (CD4 single positive (CD4SP)) or CD8 
(CD8 single positve (CD8SP)) (Fig. 22). 
Using α4 null somatic chimeras α4 integrin was reported to be essential for the 
emigration of T cell precursors from the BM to the thymus (Arroyo et al.,, 1996) 
while individual loss of α4β1 or α4β7 did not effect thymus colonisation 
(Brakebusch et al., 2002, Wagner et al., 1996). To test whether α4β1 and α4β7 
have overlapping function in this respect T cell development was studied in β1β7 
mutant BM chimeras by FACS analysis of thymocytes using the T cell specific 
markers CD4 and CD8. In contrast to the expectations the relative amount of  DN, 
DP, CD4SP and CD8SP cells in the thymus was unaltered in β1β7 mutant BM 
chimeric mice as compared to β7 mutant BM chimeras (Fig. 22). 
 
No significant difference was found in the population sizes of DN thymocytes, 
which contain the early thymic immigrants indicating that thymus colonisation 
was not altered in β1β7 mutant BM chimeric mice which lack both α4β1 and 
α4β7 integrin. Also further thymocytes maturation to DP, CD4SP and CD8SP 
cells was normal in β1β7 mutant BM chimeric mice as indicated by the similar 
population sizes in β7 mutant BM chimeras (Fig. 22). Normal numbers of CD4 
and CD8 T cells in spleen, LN and BM of β1β7 mutant BM chimeras 2 and 10 
to12 months after induction of the β1 gene deletion suggested unimpaired 
migration of these cells to secondary lymphoid organs and to the BM (Fig. 23 and 
24). Due to severe age dependent thymus involution in β7 mutant and β1β7 
mutant BM chimeras thymocytes were not analysed. 
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thy  popul. size 
(n=4/4)  β7mutant  β1β7mutant
     
DN  3.0±1.2  2.0±0.4 
DP  70.2±2.9  76.5±4.3 
CD4SP  20.0±3.4  17.3±3.0 
CD8SP  6.7±1.0  4.2±2.0 
 
 
 
 
 
 
 
 
Figure 22: Normal T cell development in the absence of β1 and β7 integrins 
Single cell suspensions from thymus of β7 mutant and β1β7 mutant BM chimeras 2 
months after polyIC injection were prepared, stained with antibodies against CD4, CD8 
and β1integrin and analysed by FACS.  
A: The dot blots show a representative staining of DN, DP, CD4SP and CD8SP 
thymocytes for both β1 mutant and β1β7 mutant BM chimeras.  
B: The averages and standard deviation of the population sizes are shown in the table for 
the respective subpopulations. (n (β7 mutant BM chimera)/( β1β7 mutant BM chimera): 
4/4).  
C: A representative histogram displays β1 integrin expression on DP T cells of β7 mutant 
(filled) and β1β7 mutant (line) mice, indicating efficient loss of β1 integrin in β1β7 BM 
chimeras. 
 
 
 
 
3. Results 46
 A 
 
BM  popul. size 
(n=4/4)  β7mutant  β1β7mutant
     
CD4+  3.7±2.3  1.8±1.5 
CD8+  2.2±1.4  1±0.4 
spleen popul. size 
(n=4/4) β7mutant  β1β7mutant
    
CD4+ 38.3±5.9  33.1±10.9 
CD8+ 11.3±4.8  8.4±3.2 
 LN  popul. size 
(n=4/4)  β7mutant  β1β7mutant
     
CD4+  57.4±7.4  56.7±1.9 
CD8+  24.0±5.8  22.7±2.4 
 
 
 
 
 
B 
BM  popul. size 
(n=5/5)  β7mutant  β1β7mutant
     
CD4SP  2.8±1.0  3.3±2.4 
CD8SP  3.5±1.0  4.4±2.2 
spleen popul. size 
(n=5/5) β7mutant  β1β7mutant
    
CD4SP 32.0±10.2  27.6±9.1 
CD8SP 11.6±6.1  14.1±7.5 
 
 LN  popul. size 
(n=3/3)  β7mutant  β1β7mutant
     
CD4SP  24.6±1.5   32.8±4.2 * 
CD8SP  13.8±2.5  22.4±8.4 
 
 
 
Fig. 23: β1β7 deficient T cells home 
normally to spleen, LN and BM 
Single cell suspensions from spleen and LN of β7 mutant and β1β7 mutant BM chimeras 
2 months (A) and 10 to 12 months (B) after polyIC treatment were prepared, stained with 
antibodies against CD4 and CD8 in combination with antibodies against β1 integrin and 
analysed in FACS. The averages and standard deviation of the population sizes are shown 
in the tables for the respective tissues, the asterisk indicates a significant difference 
according to student’s t test (p<0.05).  (n (β7 mutant BM chimera)/(β1β7 mutant BM 
chimera): 5/5).  
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In the LN of β1β7 mutant BM chimeric mice 10-12 months after the induction of 
the β1 integrin gene deletion more CD4+ and CD8+ T cells were observed. No 
conclusion can be made whether this difference is within the range of mouse to 
mouse variations or due to alterations in the migration of β1 and β7 deficient T 
cells to LN as only 3 mice were analysed. More mice need to be analysed to 
clarify this point. FACS analysis of DP thymocytes indicated an efficient loss of 
β1 integrin expression in β1β7 mutant BM chimeric mice Fig. 22C. Since CD4SP, 
CD8SP and naïve peripheral T cells express only little amounts of β1 integrin, the 
deletion efficiency in these populations was tested on genomic level. Southern 
blot analysis of thymocytes 10-12 months after the knockout induction, including 
around 20-25% CD4SP and CD8SP cells showed a gene deletion efficiency of 
more than 80% suggesting that most of the SP cells have to be β1 integrin 
deficient (Fig. 23). Southern blot of MACS beads enriched CD4 and CD8 cell 
from the spleen proved the high knockout efficiency on mature T cells (Fig. 14). 
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Figure 24: CD4+ and CD8+ T cells have an efficient deletion of the β1 integrin gene  
Single cell suspensions from spleen of β7 mutant and β1β7 mutant BM chimeras 6 
months after polyIC treatment were prepared, stained with CD4-FITC and CD8-FITC 
antibody and subsequently sorted using anti FITC MACS beads.  
A: FACS analysis of the CD4+ and CD8+ enriched fraction indicated higher than 95% 
purity (representative histogram is shown) 
B: DNA was prepared from MACS-enriched CD4+ and CD8+ splenocytes, Southern blot 
performed and densitrometically evaluated. The bar graph shows the relative amount of 
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CD4+ and CD8+ cells deficient for a functional β1 integrin gene. Error bar shows the 
standard deviation. (n (β7 mutant BM chimera)/( β1β7 mutant BM chimera): 5/5).  
These data indicate, that β1 and β7 integrins are neither essential for the migration 
of T cell precursors to the thymus, nor for T cell development and trafficking.  
 
 
 
3.6 Myeloid and erythroid development in the absence of β1 and 
β7 integrins 
 
3.6.1 Myeloid and erythroid development in vitro 
 
α4 integrins are suggested to be required for normal myeloid differentiation in 
fetal liver (Arroyo et al.,, 1999). In adult somatic α4 null chimeric mice, the 
number of myeloid cells was low and no erythrocytes were detected originating 
from α4 null HSCs. β7-null mice and β1 mutant BM chimeras, on the other hand, 
displayed normal myeloid and erythroid development (Wagner et al.,, 1996; 
Brakebusch et al., 2002). To test whether the defect described for the α4-null 
somatic chimeras can be observed in the absence of both α4β1 and α4β7 
integrins, first the capacity of myeloid and erythroid progenitors was tested to 
form granulocyte/monocyte (GM) and colony forming units (erythroid) (CFUe) 
colonies, respectively. GM colony assays were conducted with BM cells, 
splenocytes and peripheral blood after erythrocyte lysis from β7 mutant and β1β7 
mutant BM chimeric mice 2 months after the β1 integrin gene deletion. CFUe 
assays were performed with BM cells and splenocytes (Fig. 25). 
β1β7 mutant and β7 mutant control cells from all tissues formed GM and CFUe 
colonies that were morphologically similar (Fig. 25). To assess whether colonies 
derived from β1β7 mutant BM chimeric mice are deficient for β1 integrin, GM 
colonies were analysed by FACS for β1 expression (Fig. 26A) and the small 
CFUe colonies were genotyped by genomic PCR (Fig.26B).  
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  β1β7 mutant 
  β7 mutant 
CFUe 
  β1β7 mutant 
  β7 mutant  
GM 
Figure 25: Granulocyte/monocyte progenitor cells (upper panel) and erythroid 
progenitor cells (lower panel) from β1β7 mutant mice form colonies that are 
indistinguishable from β7 mutants 
Single cell suspensions were made from BM from β7 mutant and β1β7 mutant BM 
chimeras 2 months after the gene deletion. 180.000 BM cells were seeded into MethoCult 
GF M3534 medium and photographed (magnification 50x) 7 days later. For CFUe 
600.000 BM cells were seeded in MethoCult M3334, stained with benzidine 3 days later 
and photographed (magnification 100x). Examples of colonies derived from BM are 
shown. 
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Figure 26 B: Efficient loss of β1 integrin on GM precursors  of β1β7 BM chimeras 
A: Randomly picked GM colonies derived from BM, spleen or PB of mice 2 months after 
knockout induction were stained with the granulocyte marker Gr-1 in combination with 
β1 integrin and analysed by FACS. Colonies derived from β7 mutant BM chimeric mice 
are positive for β1 integrin and can clearly be distinguished from β1 negative clones 
derived from β1β7 mutant BM chimeras as the example shows. Nearly all β1β7 mutant 
colonies were β1 integrin deficient. Colonies of three mice were combined and β1+ and 
β1- colonies of β7 mutant and β1β7 mutant BM chimeras are shown as percentages, 
respectively. 
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Figure 26 B: Efficient loss of β1 integrin on  CFUe of β1β7 BM chimeras 
Genotyping of randomly picked CFUe of BM or spleen of β7 mutant and β1β7 mutant 
BM chimeras enables distinction between the β1 integrin null allele (#1), conditional 
allele (#2) and wild type allele (#3). The results of three exemplary colonies, one for each 
genotype, are shown. Genomic DNA was randomly amplified and then analysed by 
specific PCRs detecting β1 (fl), β1 (null) and β1 (wt). CFUe from β1β7 mutant BM 
chimeras were β1 deficient. Colonies of four mice were combined and β1+ and β1- 
colonies of β7 mutant and β1β7 mutant BM chimeras are shown as percentages, 
respectively. 
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All GM colonies analysed from BM (37), spleen (38) and peripheral blood (PB) 
(36) from β7 mutant mice were positive for β1 integrin as expected. From β1β7 
mutant BM chimeras only 2 of 36 colonies from the BM, 1 of 37 of the spleen and 
3 of 37 colonies derived from PB were positive for β1 integrin. All 19 CFUe 
colonies (13 in BM, 6 in spleen) derived from the β7 mutant control were positive 
for β1 integrin, while in β1β7 mutant BM only 1 of 24 colonies and none of three 
in the spleen was β1 integrin positive. This result shows first, that in the absence 
of β1 and β7 integrin granulocyte/monocyte and erythroid precursors have the 
potential to form a colony in vitro and second, that the efficiency of the β1 
integrin gene deletion is also very high on the myeloid and erythroid lineage. 
 
 
 
3.6.2 Myeloid and erythroid development in vivo 
 
To investigate the role of β1 and β7 integrins in myeloid and erythroid 
differentiation in vivo, the development of monocytes, granulocytes, and 
erythroblasts was monitored in β1β7 mutant BM chimeric mice 2 months after the 
β1 integrin gene deletion by FACS analysis using the markers Mac-1 (monocytes, 
granulocytes), Gr-1 (granulocytes), and Ter119 (erythroblasts), respectively (Fig. 
27).  
In BM of β7 mutant and β1β7 mutant BM chimeras similar amounts of 
granulocytes, monocytes and erythroblasts were observed indicating no 
developmental defects in the absence of both α4β1 and α4β7 integrins.  
To prove that HSCs and HPCs continuously provide myeloid and erythroid cells 
we analysed β1β7mutant BM chimeras 10 to 12 months after the β1 integrin gene 
deletion (Fig. 28).  
Even after 10-12 months no significant differences in the population sizes of Gr-
1+, Mac-1+ and Ter119+ cells were found between β7 mutant and β1β7mutant 
BM chimeric mice. The percentage of β1 integrin expressing Gr-1 medium cells 
increased slightly from 5.6%±4.7% at 2 months to 9.3%±2.7% at 10-12 months 
after knockout induction. Whether this points to a subtle competitive advantage of 
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β1+ granulocytes precursors versus β1 null progenitors has to be checked by 
analysis of more mice. 
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Ter119+  19.3±3.5  14.1±8.6 
β1 integrin 
Ter119 
 
 
 
 
 
 
Figure 27: β1 and β7 integrin are not essential for granulocyte, monocyte or erythroblast 
development 2 months after knockout induction 
Single cell suspensions from BM of β7 mutant and β1β7 mutant BM chimeras two 
months after polyIC treatment were prepared, stained with antibodies against Gr-1, Mac-1 
and Ter119 in combination with antibodies against β1 integrin and analysed in FACS. 
The relative size of granulocyte, granulocyte/monocyte and erythroblast subpopulations is 
shown in the table. The β1 integrin expression of immature granulocytes (Gr-1medium) 
and erythroblasts (Ter119+) of β7 mutant (filled) and the β1 expression of β1β7 mutant 
BM chimeras (line) is shown in representative histogram overlays (n (β7 mutant BM 
chimera)/( β1β7 mutant BM chimera): 4/4). 
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 BM  popul. size 
(n=5/5)  β7mutant  β1β7mutant
     
Gr-1+  61.7±7.3  50.6±17.5 
Mac-1+  66.0±6.8  60.6±11.7 
Ter119+  24.9±4.8  26.9±10.9 
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Figure 28: β1 and β7 integrin are not essential for granulocyte, monocyte or erythroblast 
development 10 to 12 months after the β1 integrin gene deletion 
Single cell suspensions from BM of β7 mutant and β1β7 mutant BM chimeras 10 to 12 
months after polyIC treatment were prepared. 
A: Cells were stained with antibodies against Gr-1, Mac-1 and Ter119 in combination 
with antibodies against β1 integrin and analysed in FACS. The relative size of 
granulocyte, granulocyte/monocyte and erythroblast subpopulations is shown in the table. 
(n (β7 mutant BM chimera)/( β1β7 mutant BM chimera): 5/5).  
B: The β1 integrin expression of Gr-1 med cells was assessed by staining for Gr-1 in 
combination with β1 integrin. This population has very high β1 expression levels and was 
therefore chosen  to monitor the deletion efficiency. Error bars show the standard 
deviation. (n (β7 mutant BM chimera)/( β1β7 mutant BM chimera): 2 mo (4/4); 10-12 mo 
5/5). 
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3.6.3 Migration of granulocyte/monocyte progenitors to secondary lymphoid 
organs 
 
During our investigation of the possible functional redundancy of β1 and β7 
integrin in the hematopoietic system and the analysis of the blood cell 
development in the absence of both α4β1 and α4β7 integrin, a function of α4 
integrin for the distribution of blood cell progenitors was reported (Scott et al., 
2003). The authors of this study generated α4 conditional knockout mice with a 
Mx-cre mediated deletion, but did not restrict the gene deletion to the 
hematopoietic system by transplanting BM into lethally irradiated wild type mice. 
In this system, the authors found that CFU-C progenitors, comparable to GM 
colony forming units, occurred in similar number in the BM (52.488±7.543 per 
femur in α4 mutants versus 49.554±3.615 per femur in controls), but were more 
numerous in the PB of α4 mutant mice leading to an increase from 142±13 CFU-
C/ml in control mice to 1.177±71 CFU-C/ml in mice two weeks after the 
induction of the gene ablation. The increased amount of progenitors in the 
periphery of the α4 deficient mice therefore did not correspond to a decrease of 
progenitors in the BM. At that time the number of progenitor cells within the 
spleen was moderately increased from 29.538±2.549 in controls to 
39.994±3.680/spleen in deletion-induced mice. 6 months after the gene deletion 
the number of CFU-C was elevated by approximately 30% in BM and 160% in 
spleen compared to control animals. 
To test whether there are similar alterations in β1β7 mutant BM chimeras 
compared to β7 mutant controls, the frequency of GM progenitors (equivalent to 
CFU-C) was assessed in BM, PB and spleen 2, 6 and 10 months after the β1 
integrin gene deletion (Fig. 29). 
These data indicate that after deletion of β1 and β7 integrin in BM chimeric mice 
the number of GM progenitors in the BM increases after 2 months roughly two-
fold, but becomes normal again at 6 months and 10 months. Correspondingly, GM 
progenitor numbers in PB were increased more than two-fold 2 months after ko 
induction, but normal at 6 or 10 months. In spleen, the number of GM progenitors 
was unchanged 2 months after the induction of the β1 gene deletion, but 
decreased in β1β7 mutant BM chimeras after 10 months. 
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Figure 29: Distribution of granulocyte/monocyte progenitors 
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Single cell suspensions were made from BM and spleen and erythrocytes were lysed of 
blood from β7 mutant and β1β7 mutant BM chimeras at indicated times after the gene 
deletion. 180.000 BM cells, 3.600.000 splenocytes and 250µl PB were seeded into 
MethoCult GF M3534 medium and counted seven days later. Total numbers of colonies 
per femur, spleen and ml PB are shown. Error bars show the standard deviation. (n (β7 
mutant BM chimera)/( β1β7 mutant BM chimera): 2 months 5/5, 6 months 4/4, 10 
months 3/3).  
 
These data would be consistent with a model where combined loss of β1 and β7 
integrin leads to increased production of progenitors in the BM, a proportionally 
increased release of progenitors to the blood and inefficient migration of these 
progenitors to the spleen. Compared to the published data the increase of 
progenitors in PB is lower in β1β7 mutant BM chimeras and no increase of 
progenitors was observed in the spleen.  
One explanation for these differences between the non-BM transplanted α4 
integrin deficient mice and the β1β7 BM chimeras could be the different technical 
systems used. In order to address this question, the frequency of GM progenitors 
was determined in PB of β1β7 mutant mice that were not BM-transplanted. There 
the number of progenitors in PB increased about 8 fold from 95±33 in β7 mutant 
controls to 764±400 in β1β7 double mutant mice four weeks after induced gene 
deletion (n=5), which is more similar to the reported 11-fold increase from 
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100±46 in controls to 1150±120 in α4 deficient mice (n=4). These results suggest 
that the different systems used to investigate the role of α4β1 and α4β7 integrins 
in hematopoietic progenitor distribution might explain in part the difference in the 
results obtained. 
 
 
 
3.7 Surface expression of α4 integrin in the absence β1 and β7 
integrins  
 
The more severe hematopoietic phenotype observed in α4 null somatic chimeras 
compared to β1β7 mutant BM chimeras prompted us to test whether β1β7 mutant 
BM chimeras might still express α4 integrin on the cell surface which could 
compensate for the loss of α4β1 and α4β7 integrins. We therefore checked by 
FACS, whether there are cells that express α4 integrin but not β1 and β7. 
Analysis of BM, PB, thymus and spleen revealed that only in BM of β1β7 mutant 
mice such a population of α4+β1- β7- cells exists (Fig. 30). 
This cell population was found independently of the time after the induction of the 
β1 gene deletion only in the BM and accounted for 5%-20% of total BM cells in 
β1β7 mutant mice. 
To exclude that this antibody staining was obtained due to unspecific cross-
reaction, different anti α4 antibody clones were used in FACS (Fig. 31). Of these 
monoclonal antibodies 9C19 and R1-2 were reported to recognize different 
epitopes (Kinashi et al., 1994, Lin et al., 1995). 
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Figure 30: Cells that are negative for β1 and β7, but do express α4 integrin on the cell 
surface in the BM of β1β7 mutant BM chimeras. 
Peripheral blood and single cell suspensions from BM, spleen, thymus of β7 mutant and 
β1β7 mutant BM chimeras were prepared, stained with antibodies against α4 integrin and 
β1 integrin and analysed by FACS. 
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Figure 31: Three different clones of anti α4 antibodies recognise the α4 integrin on the 
surface of erythroblasts in the absence of β1 and β7 integrins 
Single cell suspension from β1β7 mutant BM was prepared, stained with Ter119 and β1 
and β7 integrin in combination with different clones of α4 integrin antibodies and 
subsequently analysed by FACS. The histograms show the α4 integrin expression of 
Ter119+, β1- and β7- integrin cells as assessed by the indicated clone. The filled curve 
represents the background and the line the antibody staining. A donkey anti rat Cy5 
labelled secondary antibody was used to detect the clone PS/2. The clones 9C10 and R1-2 
were directly PE-labelled. 
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While the clones 9C10 and R1-2 gave comparable signals, the clone PS/2 gave a 
weaker signal but was clearly different from the background staining. This 
experiment shows that different monoclonal antibodies can detect the α4 integrin 
chain on the cell surface in the absence of β1 and β7. Therefore it can be excluded 
that the signal obtained is due to some non-specific binding of one clone. 
Furthermore, this result indirectly suggests that the α4 subunit is correctly folded, 
since it is not likely that all tested monoclonal antibodies recognise a denatured 
α4 integrin.  
To further characterize this α4+ β1- β7- cell population, BM cells from β1β7 
mutant BM chimeras were stained for α4 and β1 integrin and additionally for 
lineage affiliated markers (Fig. 32). 
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Figure 32: The majority of β1β7 negative, α4 positive cells in the BM are Ter119+ 
erythroblasts 
Single cell suspensions from BM of β1β7 mutant mice 6 months after polyIC treatment 
was prepared, triple stained with antibodies against α4 integrin, β1 integrin and lineage 
markers and subsequently analysed by FACS. Histograms show only α4+, β1-, β7- cells 
gated out as shown in the α4/β1 integrin dotplot. 
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The majority of cells (∼90%) expressing α4 integrin, but not β1 and β7 appeared 
to be erythroblasts. 4-5% of the α4+ β1- β7- cells were Mac-1+ monocytes, while 
B cells, T cells and granulocytes were hardly detected.   
It is not clear, whether also erythroblasts of wild type or β7 mutant mice express 
surface α4 not bound to β1or β7, since this particular cell population might be 
hidden in the vast amount of cells positive for α4 and β1 integrin (Fig. 33). 
 
 
 
 
 
 
 
 
 
 
Ter 119 β1 integrin
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Figure 33: BM cells with high α4 integrin levels are predominantly erythroblasts. 
Single cell suspensions from BM of β7 mutant BM chimeras was prepared, stained with 
antibodies against α4 integrin and β1 integrin and analysed by FACS. 
 
However, also in β7 mutant mice erythroblasts express the highest amounts of α4 
integrin. 
To test whether a certain developmental stage of erythroblasts contributes more 
than another to the α4+ β1- β7- cells in β1β7 mutant BM chimeras a Ter119 - 
CD71 double staining was performed that allows the separation of BM 
erythroblasts into five different maturation stages (Socolovsky et al., 2001) (Fig. 
34). The α4 and the β1 integrin expression of each of these stages were assessed 
in β7 mutant and β1β7 mutant mice. 
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Figure 34 A: All developmental stages of erythroid cells contribute to the α4+ β1- β7-  
population. 
BM single cell suspensions from β1β7 mutant BM chimeras that were phenylhydrazine 
(PHZ) treated were prepared. Cells were stained with antibodies against α4, β1 integrin, 
CD71 and Ter119 and subsequently analysed by FACS. (Ter119-CD71 staining 
distinguished 5 different developmental stages.) The α4 and β1 expression was plotted 
for each developmental stage of erythroid cells. 
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Figure 34 B: All developmental stages of erythroid cells contribute to the α4+ β1- β7-  
population. 
The bar graphs show the percentage of cells that are α4-β1- (all α4- cells), α4+β1+ (all 
β1+ cells) and α4+β1- (remaining cells), respectively. Error bars show the standard 
deviation. (n (β7 mutants )/( β1β7 mutants): 3/3).  
 
The analysis revealed the presence of α4+β1- cells in each stage of erythroid 
development. The percentage of α4+β1- cells varies between 40% and 60% in the 
first 4 stages and decreases drastically in stage 5, because erythroblasts 
downregulate integrin expression during final maturation. 
 
α4 integrin was reported to be important for the retention of HPC cells within the 
BM (Papayanopoulou et a., 1995; van der Loo et al.,, 1998). To test whether also 
HSCs and HPCs express α4 integrin in the absence of β1 and β7, we gated β1β7 
mutant BM cells for lineage marker deficient (lin-), β1- and c-kit+ cells. This 
population was plotted for Sca-1 and α4 integrin. HSCs are lin-, c-kit+ and sca-
1+, while HPCs are lin-, c-kit+ and Sca-1- (Fig. 35). The analysis of three mice 10 
months after the β1 integrin gene deletion revealed that almost all of the HSCs 
(88.6%±4.1%) and HPCs (93.7±1.5%) were α4 integrin positive in β7 mutant BM 
chimeras, as expected. In β1β7 mutant BM chimeric mice, however, no 
significant subpopulation of HSCs (14.4%±2.5%) was found to express α4 
3. Results 64
integrin, but 51.1%±4.7% of the HPCs expressed α4 in the absence of β1 and β7 
integrin. 
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Figure 35: Approximately 50% of all HPCs,  but hardly any HSCs  express α4 integrin in 
the absence of β1 and β7 integrin in β1β7 mutant BM chimeric mice. 
Single cell suspensions from β7 mutant and β1β7 mutant BM 10 months after the β1 
integrin gene deletion was prepared, stained with a cocktail of lineage markers, c-kit and 
Sca-1 in combination with α4 integrin and subsequently analysed by FACS. The dot blots 
show the α4 integrin expression of lineage-, c-kit+ and Sca-1- cells (HPCs) and lineage-, 
c-kit+ and Sca-1+ cells (HSCs). In case of the β1β7 mutant BM, β1 integrin positive cells 
that might occur due to an incomplete gene deletion are excluded from the analysis. 
 
 
 
3.8 Functional analysis of α4+ β1- β7- cells  
 
Although the previous experiments demonstrated surface expression of α4 
integrin in the absence of β1 and β7 integrin, they gave no information about a 
possible function of this α4 subunit present either as a monomer or complexed 
with other molecules. Therefore we tested whether cells positive for α4 and 
negative for β1 and β7 integrin can bind VCAM-1 which is a known ligand of α4 
integrins. BM cells with an incomplete deletion of β1 integrin were incubated 
with fluorescently labelled VCAM-1 and then stained for α4 and β1 integrin in 
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the presence of EDTA or in the presence of Mn2+. Mn2+ induces a high affinity 
conformation of integrin heterodimers by binding to the β subunit. Mn2+ was 
added here in case α4 integrin is heterodimerizing with another β subunit than β1 
and β7. In the presence of EDTA integrin are in a low affinity conformation. 
α4+β1+ cells bound VCAM-1 in a Mn2+ dependent manner, while α4+, β1- cells 
did not (Fig.36). 
VCAM-1 
α4 integrin 
β1 integrin 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 36: α4+β+-β7- BM cells bind VCAM-1 in a Mn2+ inducible manner, while 
α4+β1-β7- BM cells do not. 
Single cell suspensions from β7 mutant and β1β7 mutant BM were prepared, incubated 
with fluorescently labelled VCAM-1 in either EDTA or Mn2+ containing buffer, stained 
for α4 and β1 integrin and analysed by FACS. α4+β1- and α4+β1+ subpopulations were 
gated out and analysed for autofluorescence (filled) and VCAM-1 binding (line). 
 
 
 
 
3.9 Expansion of erythrocyte precursors after anaemia 
 
After phenylhydrazine (PHZ) induced lysis of erythrocytes in vivo, the erythroid 
precursor cells have to expand in order to compensate the loss of erythrocytes. In 
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addition, haemolytic anaemia promotes extramedullary erythropoiesis leading to 
proliferation of progenitors in the spleen (Nijhof et al., 1983). Since in α4 
conditional knockout mice the ability of erythroblasts to expand in response to a 
PHZ induced haemolytic anaemia was reduced (Scott et al., 2003), we 
investigated whether combined loss of β1 and β7 integrin have a similar effect. 
For better comparison with the non BM-transplanted α4 mutant mice we used non 
BM-transplanted β1β7 mutant mice. Therefore we analysed the number of 
erythrocytes, erythroblasts and the total number of CFUe after two daily injections 
of 60mg of PHZ per kg mouse weight. In addition we tested, whether the α4+β1-
β7- erythroblasts expand differently and whether they can be found in the spleen 
under these conditions. The effect of the PHZ treatment was followed by 
measuring the amount of erythrocytes identified by their FSC/SSC characteristics 
among Ter119+ cells using FACS (Fig. 37).  
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Figure 37: PHZ treatment leads to a relative reduction of erythrocytes in BM and in 
spleen 
Single cell suspensions from β7 mutant and β1β7 mutant BM and spleen were prepared, 
stained for Ter119 and analysed by FACS. Erythrocytes were identified among Ter119+ 
cells by their FSC/SSC characteristics. Error bars show the standard deviation. (n (β7 
mutants )/( β1β7 mutants): BM and spleen untreated 3/3; BM and spleen PHZ treated 
5/5).  
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In BM and spleen of all mice the PHZ treatment led to a severe reduction of the 
amount of erythrocytes as compared to untreated mice indicating that PHZ 
treatment was effective. No differences were observed in the effect of PHZ on 
erythrocytes between β1β7 mutant mice and β7 mutant controls.  
In contrast to erythrocytes, erythroblasts numbers in the BM increased after PHZ 
treatment (Fig. 38). No significant difference was observed between β1β7 mutant 
mice and β7 mutant controls. These data are in contrast to data from the α4 
mutant mice, where loss of α4 corresponded to a 33% reduction in erythroblast 
numbers in BM. 
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Figure 38: β1β7 mutant mice do not display a delayed recovery from hemolytic anaemia 
as compared to β7 mutants  
Single cell suspensions from BM of β7 mutant and β1β7 mutant mice (no BM 
transplantation) untreated and treated with PHZ were prepared, stained with Ter119 
antibody and subsequently analysed by FACS. The total amount of Ter119+ erythroblasts 
per femur is shown. Error bars show the standard deviation. (n (β7 mutants )/( β1β7 
mutants): 5/5).  
 
In the spleens of β1β7 mutant mice the number of erythroblasts after PHZ 
treatment tended to be higher (48.2±13.4) than the amount in β7 mutant controls 
(35.7±9.5), but this difference was not significant. The results indicate that β1β7 
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mutant and β7 mutant erythroblasts have similar capacity to expand in order to 
compensate for the reduced erythrocyte number.   
The amount of CFUe after PHZ treatment was similar in the BM of β7 mutant 
controls and β1β7 mutant mice but was strongly decreased in the spleen of β1β7 
mutants compared to β7 mutant controls (Fig. 39), whereas for α4 mutant mice a 
decrease in the BM but no change in the spleen as compared to control mice was 
reported. 
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Figure 39: Severely reduced CFUe after PHZ treatment in spleens of β1β7 mutant mice 
Single cell suspensions were made from BM and spleen from β7 mutant and β1β7 mutant 
mice (no BM transplantation). BM cells and splenocytes were seeded into MethoCult 
3334 medium and counted three days later. Total numbers of colonies per femur and 
spleen are shown. Error bars show the standard deviation. (n (β7 mutant BM chimera)/( 
β1β7 mutant BM chimera): 3/3).  
 
These data suggest that β1β7 mutant mice do not display a delayed recovery from 
PHZ induced anaemia in BM as compared to β7 mutant controls. The decreased 
frequency of CFUe in the spleen, however, points to a defect of PHZ treated mice 
of β1β7 mutant erythroid precursors to colonise this organ leading to a decrease of 
the total amount of all CFUe per mouse in the β1β7 mutant mice compared to β7 
mutant controls.  
BM cells and splenocytes of PHZ treated mice were stained for α4 and β1 integrin 
to test whether α4+β1-β7- cells can be mobilised under conditions of acute 
haemolysis. However, significant amounts of α4+β1-β7- cells were only 
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encountered in the BM of β1β7 mutant mice. These amounts were comparable to 
those of untreated β1β7 mutants (Fig. 40). 
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Figure 40: α4+β1-β7- cells occur also under conditions of haemolytic recovery only in 
the BM of β1β7mutant mice. 
Single cell suspensions from BM and spleen of β7 mutant and β1β7 mutant mice (no BM 
transplantation) after PHZ treatment were prepared, stained with α4 and β1 integrin 
antibodies and subsequently analysed by FACS.  
A: The percentage of α4+β1-β7- cells is shown. Error bars show the standard deviation. 
(n (β7 mutants )/( β1β7 mutants): 3/3). 
B: A representative example of an α4 β1 integrin staining of β1β7 mutant BM cells and 
splenocytes.  
 
 
 
3.10 Attempts to identify α4 associated cellular protein in the 
absence of β1 and β7 integrin 
 
3.10.1 Co-immunoprecipitation using an anti α4 integrin antibody 
 
To clarify whether α4 integrin is associated with another molecule or reaches the 
cell surface as a monomer immunoprecipitations (IPs) were conducted. First 
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5x107 BM cells from wild type mice were isolated and radiolabelled using 125I. 
Cells were lysed and  IPs were performed using an anti α4 integrin antibody and 
as a control experiment using an anti αM integrin antibody. The supernatants and 
the precipitates were electrophoretically separated on a SDS-PAGE and analysed 
by autoradiography (Fig. 41).  
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Figure 41: Using wild type BM β1 and β7 integrins could be co-immunop
α4 integrin Single cell suspension from BM of wild type mice was pr
radiolabelled using 125I and lysed. The Lysate was immunoprecipitated (p
α4 and anti αM antibodies, separated on a polyacrylamide gel and autor
analysed. For the α4-IP, also supernatant (sup.) of the IP is shown as a con
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a 130kD band fitting to the size of β1 and β7 integrin suggesting that β1 and β7 
integrin were detected, can be co-immunoprecipitated with α4. Additional bands 
around 80kD and 70kD correlate very likely to known degradation products of α4 
integrin (Altevogt et al.,, 1995). 
 
Using the same approach, we wanted to test whether in the absence of β1 and β7 
integrin α4 integrin can bind to intracellular ligands such as paxillin, which was 
described to bind to α4 integrin directly (Liu et al., 1999). Using 3x107 wild type 
BM cells an α4 integrin IP was performed to establish the method. The 
supernatant and the precipitate were electrophoretically separated, blotted on a 
membrane and probed with anti paxillin antibody (Fig. 42). 
 
sup. prec. Figure 42: Using wild type BM paxillin 
could be co-immunoprecipitated with 
α4 integrin 
Single cell suspension from BM of wild 
type mice was prepared, the lysed and 
immunoprecipitated using anti α4 
antibody. The Precipitate (prec.) and an 
aliquot of the supernatant were 
separated on a polyacrylamide gel and 
probed with an anti paxillin antibody. 
(heavy Ig chain) 
      50 kD 
(paxillin) 70 kD 
 
Paxillin was clearly enriched in the precipitate as compared to the lysate, 
indicating that it co-immunoprecipitates with α4 integrin. The second band in the 
precipitate is most likely due to recognition of the immunoglobulin heavy chain of 
the α4 antibody used for the IP by the secondary antibody used for paxillin 
detection. 
Using the same techniques we tried to co-immunoprecipitate α4 integrin 
associated molecules in lysates of surface-iodinated BM cells of β1β7 mutant 
mice. For each experiment BM of 3 β1β7 mutant mice was combined. However, 
due to low expression levels of α4 integrin restricted to a subpopulation of BM 
cells of β1β7 mutant mice, it was very difficult to obtain convincing 
immunoprecipitations of α4 integrin itself. Based on the intensity of the α4 
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staining in FACS  and considering that the α4+β1-β7- cells account for 5%-20% 
of total BM cells, the cell number used for one experiment needs to be increased 
by 25 to 35 fold to obtain similar amounts of α4 molecules. This would mean that 
BM of approximately 30 mice should be combined. Such an experiment should be 
carried out in the future. 
 
 
 
3.10.2 Analysis of α4 integrin expression on β1β2 mutant BM cells 
 
β2 integrin is expressed on all leukocytes in high amounts. Although it was not 
described to associate with α4 integrin it might do so in the absence of β1 and β7 
integrin, explaining the presence of α4 integrin on the cell surface of β1β7 mutant 
cells. To test whether β2 integrin can associate with α4 on BM cells, we 
intercrossed β1 conditional Mx-cre positive mice with β2 integrin null mice 
(Scharffetter-Kochanek, K. et al., 1998) to obtain β1β2 mutant mice after polyIC 
treatment. FACS analysis was carried out for α4, β1 and β7 integrin and α4 and 
β1 expression was tested on BM cells gated for the absence of β7 integrin (Fig. 
43). 
β2 mutant β1β2 mutant 
α4 integrin 
β1 integrin 
 
 
 
 
 
 
 
 
 
 
Figure 43: BM cells of β1β2 mutant mice contain cells that are negative for β1, β2 and 
β7, but do express α4 integrin on the cell surface. 
Single cell suspensions from BM of β2 mutant and β1β2 mutant mice were prepared, 
stained with antibodies against α4, β1, β2 and β7 integrin and analysed by FACS. Shown 
is the α4, β1 expression of β7- cells. One representative experiment of three is shown. 
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Also on cells lacking β1, β7 and β2 integrin α4 integrin was found on the cell 
surface, indicating that β2 integrin is not heterodimerizing with α4 integrin. 
 
 
 
3.10.3 Generation and analysis of integrin mutant fibroblastoid cells 
 
To test whether the appearance of α4 integrin on the cell surface in the absence of 
β1 and β7 is restricted to hematopoietic cells or not we infected fibroblastoid cells 
lacking β1 integrin (GD25) and corresponding control cells expressing β1 (GD25 
β1+) (Wennerberg et al., 1996) with a retrovirus containing cDNA encoding for 
α4 integrin. We expected these cells to be a suitable model since GD25 cells were 
deficient for β1 integrin and do not express β7 on the surface as tested previously. 
FACS analysis revealed, however, that GD25 β1- cells showed α4 integrin 
expression on the cell surface as well as β7 integrin, while GD25 β1+ cells were 
positive for α4, β1 and β7 integrin (Fig. 44). 
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Figure 44: GD25 β1+ and GD25 β1- fibroblastoid cells do neit
integrin. Upon infection with α4 integrin cDNA, however, both c
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GD25 β1+ and GD25 β1- cells were before and after infec
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If β7 integrin mRNA is expressed in GD25 cells lacking β1 integrin only after 
ectopic α4 expression, it could indicate that α4 integrin induces signalling that 
leads to β7 integrin expression. To test this possibility RT-PCR was carried out 
for β7 integrin mRNA in α4 transfected and untransfected GD25 and GD25β1 
cells (Fig. 45). 
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BM  
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Figure 45: GD25β1 and GD25  fibroblastoid cells do express β7 mRNA prior to α4 
infection. 
RNA from GD25β1 and GD25 cells was isolated before and after infection with a 
retrovirus containing α4 integrin cDNA and subjected to β7 integrin RT-PCR analysis as 
indicated. RNA isolated from wild type BM cells served as a positive control.  
 
Clearly, also in the absence of α4 integrin β7 mRNA is present in GD25 and 
GD25β1 cells. Whether expression of α4 results in an upregulation of β7 integrin 
expression should be tested by quantitative RT-PCR or Northern blot.  
To circumvent the problem of cytoplasmic β7 integrin in GD25 cells we 
generated fibroblastoid cell lines from embryos deficient for β2 and β7 integrin 
carrying a conditional deletion of the β1 integrin gene. By adenoviral cre infection 
in vitro cell lines lacking β1, β2 and β7 were generated. After infection of those 
cells with α4 integrin cDNA, FACS analysis revealed that also in fibroblastoid 
cells α4 integrin can reach the cell surface in the absence of β1, β2 and β7 
integrins (Fig. 46). 
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Figure 46: Fibroblastoid cells deficient for β1, β2 and β7 integrin express α4 integrin on 
the cell surface upon infection with α4 integrin cDNA. 
Fibroblastoid cells deficient for β1, β2 and β7 integrin were stained with antibodies 
against α4 and analysed by FACS before and after infection with a retrovirus containing 
α4 integrin cDNA. The deficiency of β1, β2 and β7 integrin on these cells was confirmed 
by FACS analysis. Shown is an overlay of a representative α4 staining of cells before 
(line) and after retroviral infection with a virus containing α4 integrin cDNA (filled).  
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4. Discussion 
 
 
In this PhD work, the functional role of the β1- and β7 integrin receptors for the 
murine hematopoietic system were studied in vivo. Surprisingly, β1- and β7 
integrins are not essential for the retention, proliferation and survival of HSC and 
HPC within the BM. Furthermore, hematopoiesis and lymphopoiesis are not 
dependent on the adhesive interactions nor signal transduction mediated by these 
integrins, suggesting compensatory effects of other adhesion receptors. Finally, 
the analysis revealed cell populations expressing α4 integrin in the absence of β1 
and β7. This α4 integrin expression could contribute to the mild phenotype of 
β1β7 mutant BM chimeras. 
 
 
4.1 Retention and function of HSC 
 
In adult mammals HSCs are retained in the BM where they self-renew and 
differentiate into HPCs giving rise to the different blood cell lineages. Integrins 
are thought to be crucial for the retention and maintenance of HSCs in the BM, 
although up to now no single integrin receptor could be found that is essential for 
HSC function in the BM. Several experimental evidences suggested that β1 
integrin-mediated adhesion of HSC/HPCs is important for their function in the 
BM (Prosper and Verfaille 2001). First, β1 integrins were thought to be crucial for 
the adhesion of hematopoietic cells to stroma cells and to the extracellular matrix 
(ECM) in the BM. Fibronectin (FN) is a component of the BM ECM and in vitro 
experiments demonstrated that adhesion of HSC and HPC to fibronectin is 
mediated by α4β1 as well as α5β1 (Williams et al., 1991; van der Loo et al., 
1998). Integrin α4β1 also mediates binding to VCAM-1, which is expressed on 
BM stroma cells (Oostendorp et al., 1995). The importance of these interactions 
for the retention of HPC and HSC was supported by intravenous injection of FN 
fragments and antibodies against α4, blocking α4β1 and α4β7, or VCAM-1, 
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which mobilised HPC into the blood (Papayannopoulou, 1995; van der Loo et al., 
1998). Release of HPCs can also be induced by other mobilising agents such as 
stem cell factor (c-kit ligand), IL-3, granulocyte-macrophage colony stimulating 
factor and others (Fruehauf, 2003). The α4 integrin expression level on 
HSCs/HPCs mobilized by G-CSF was shown to be reduced compared to steady-
state BM and PB cells (Chen et al. 2003), again suggesting an important role for 
α4 integrins in HPC retention in the BM. In addition to retention of HSC and 
HPC in the BM, integrin mediated adhesion might also be crucial for the self-
renewal and survival of HSC, since α4β1-mediated attachment of HPC to FN 
promotes proliferation (Yokota et al., 1998; Schoefield, 1998) and prevents 
apoptosis (Wang et al., 1998).  
At the time this study was initiated, however, several genetic approaches pointed 
to a less prominent role of these integrin receptors for HSC/HPC retention and 
function. In β1 integrin mutant mice, there was no evidence for an increased 
release of HSCs/HPCs into the periphery as the numbers of progenitor cells in PB 
were normal (Brakebusch et al., 2002). Normal hematopoiesis in these mice, even 
12 months after the knockout induction, revealed no functional abnormalities of 
hematopoietic progenitors in the absence of β1 integrins. Likewise, no defects in 
the retention of HSC/HPC leading to abnormal hematopoiesis were apparent in β7 
knockout mice (Wagner et al. 1996). Furthermore, data obtained with α4-null 
chimeric mice could not confirm an essential role of α4 integrins as these mice 
show normal function, retention and maintenance of HSC despite of the absence 
of α4β1 and α4β7 (Arroyo et al., 1996, 1999). Mice lacking VCAM-1 on 
endothelial and hematopoietic cells showed a reduced migration of lymphocytes 
to the BM, but no impaired HSC function (Koni et al., 2001; Leuker et al., 2001; 
Friedrich et al., 1996). Genetic studies of α5- or αv-null chimeric mice and of 
mice deficient for α1, α2, α3, α6, α7, α8, α9, α10, αL, αM, β2, β3, β4, β5, β6 
and β8-deficient mice revealed that none of these integrins is essential for the 
retention of HSC in the BM (reviewed by Hynes, 2002).  
In the midst of this PhD project an analysis of a conditional knockout of α4 
integrin was published which demonstrated a role of α4 in HSC/HPC retention 
(Scott et al., 2003). In these mice, which lack α4β1 and α4β7 integrins in the 
hematopoietic system and at least partially in many other tissues, HPC numbers in 
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the PB were elevated indicating a release from the BM. However, the HPC 
numbers were not decreased in the BM leading to a higher total amount of HPCs 
per mouse. This increase could be due to a release of HPCs from the BM which is 
then compensated by upregulated formation of HPCs. Alternatively, the loss of α4 
integrins might lead to an enhanced formation of HPCs, which are then released 
into the periphery suggesting a role of α4 integrin in HPC expansion apart from 
its adhesive function. 
In contrast to these reported findings, the results presented in this study show that 
simultaneous loss of all β1 and β7 integrin receptors, including α4β1 and α4β7, 
did not severely impair HSC retention or function. The mutant mice exhibited 
normal hematopoiesis and had normal numbers of BM cells. The overall number 
of progenitors was increased about two-fold in BM and blood, which would fit to 
an increased release due to increased production of HSCs/HPCs in the BM. The 
maintenance of β1β7 null HSCs was proven by their high contribution to all 
hematopoietic lineages even 12 months after knockout induction, as analysed by 
FACS, Southern blot and genotyping of progenitor colonies. Comparison of the 
knockout efficiency on myeloid cells in the BM of β1β7 mutant BM chimera 2 
and 10 to 12 months after knockout induction showed a slight, but not significant, 
decrease of the percentage of β1β7 deficient cells. This could indicate that the β1 
integrin expressing HSC in β1β7 mutant BM chimeras, which are always present 
due to the incomplete knockout of the β1 integrin gene, have a growth advantage 
over β1β7-deficient HSC. Such an advantage could be caused by decreased 
proliferation or increased apoptosis of β1β7-mutant cells. Whether this subtle 
difference is indeed caused by a growth advantage of β1 expressing HPC or 
whether it is caused by mouse-to-mouse variations of the donor BM is not clear. 
Comparison with the mouse-to-mouse variation of knockout efficiencies on HPC-
derived colonies and differentiated cells, however, favour the latter explanation. 
One explanation for the reported strong increase in the relative release of HPCs 
from the BM of α4 integrin conditional knockout mice could be that the deletion 
of the α4 integrin gene was not restricted to the hematopoietic system. For 
example, loss of α4 in non-hematopoietic tissues such as vasculature, BM stroma 
cells or endothelial cells might result in the production of cytokines which favour 
the mobilisation of HPCs. This explanation is supported by the fact that mice 
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lacking β1 and β7 integrin with a similar tissue distribution as the α4 conditional 
knockout mice show a comparable relative release of HPCs into the peripheral 
blood as was shown in this PhD study using non-BM-transplanted mice. This 
explanation might also apply for antibody and peptide inhibition studies since 
these agents can bind to many other integrin-expressing cells where they might 
induce secondary effects indirectly favouring the release of HSC into the blood 
before reaching the HSCs in the BM. Cytokine mediated release of HPCs into the 
PB peaks from day 4 to 7 after administration of the respective agent (Fruehauf 
2003). One would expect a more rapid release mediated by blocking antibodies 
and peptides, however, the earliest time point assessed was 4 days after agent 
administration. Therefore, the kinetics of blocking agents versus cytokine 
mediated release should be determined to address the mechanism underlying HPC 
release into the PB. 
In addition, the presence of α4 integrin on the surface of approximately 50% of 
the HPCs in the absence of β1 and β7 could contribute to the mild phenotype. 
However, the strong release of HPCs form the BM to the periphery of non-BM-
transplanted β1β7 mutant mice indicates that α4 expression in the absence of β1 
and β7 is probably not responsible for the HPC retention in β1β7 mutant BM 
chimeras. 
Since HSCs/HPCs are retained and functioning in β1β7 mutant BM chimeras, 
other HSC adhesion receptors may compensate for the loss of β1 and β7 integrins.  
The adhesion receptors still present in the β1β7-null BM chimeras might be 
sufficient for HSC maintenance, function and retention. One possibility is the 
fibronectin and hyaluronan-binding CD44 molecule which itself is not crucial for 
HSC retention and maintenance as revealed in mice lacking the CD44 gene 
(Schmits et al., 1997). Integrins containing the β2 subunit might compensate for 
the loss of β1 and β7 integrins, although they are normally not expressed on HSC, 
but on leukocytes (Voura et. al., 1997). It remains to be examined if the 
expression of other adhesion receptors is upregulated in response to the loss of β1- 
and β7 integrins. To address this question, HSC should be purified by FACS and 
tested for the expression levels of different receptors. Quite likely, αv integrins 
mediate compensating adhesive interactions and prevent HSC release from the 
BM as all αv integrins bind to FN in a manner similar to α4β7. A triple knockout 
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of αv, β1 and β7 would elucidate whether this is the case. Alternatively, in vitro 
cultures could be established to assess the adhesion of wild type and mutant HSC 
to a basic layer of BM stroma cells. Treatment with different antibodies blocking 
ligand binding to specific adhesion receptors should determine which adhesion 
receptors mediate the attachment of wild type and mutant HSC to the stroma cells. 
Although it seems unlikely, it cannot be excluded that the loss of β1 integrin 
receptors, different from α4β1, rescue the phenotype observed in α4 deficient 
mice. 
 
 
 
4.2 Lymphopoiesis 
 
In adult mice, lymphopoiesis originates in the BM. While B cells mature in the 
BM, T cell precursors leave the BM and enter the blood stream to colonize the 
thymus and mature there. Previous in vitro experiments indicated a stroma 
dependent phase for early B cell development and suggested a role for 
α4β1 integrin (Gisler et al., 1987). The function of α4 integrins has also been 
studied in vivo. To circumvent embryonic lethality of α4-deficient mice, somatic 
chimeric mice were generated by injecting α4 null ES cells into α4+/+ RAG-1- or 
RAG-2- blastocysts (Arroyo et al., 1996). Since RAG-1 and RAG-2 deficient 
mice do not develop any mature lymphocytes, all mature lymphocytes in the 
chimera should be derived from the α4-/- ES cells. However, also non-lymphoid 
cells are derived from the α4-null ES cells resulting in a knockout that is not 
restricted to the hematopoietic system. The analysis of these α4-null chimeric 
mice, which lack both α4β1 and α4β7 on all cells derived from α4 null ES cells, 
revealed an important role for α4 integrin in lymphopoiesis (Arroyo et al., 1996; 
Arroyo et al., 1999). In the absence of α4 integrin, B cell development stopped 
before the pro B cell stage. In addition, T cell precursors were unable to leave the 
BM. However, injection of α4 null BM cells into the blood of RAG-2 mice 
resulted in normal colonisation of the thymus, indicating that α4 integrin is 
neither important for the homing of T cell precursors to the thymus nor for 
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intrathymic development, but is important specifically for extravasation out of the 
BM. Since β7 knockout mice, which lack only α4β7, have normal hematopoiesis 
(Wagner et al., 1996), it was concluded that α4β1, and not α4β7, plays a crucial 
role in lymphopoiesis (Wagner et al., 1998). Yet, analysis of β1 mutant BM 
chimeras demonstrated that β1 integrins, including α4β1, are not essential for 
lymphopoiesis (Brakebusch et al., 2002). The analysis of B cell development in 
BM and spleen did not reveal any gross abnormality in the differentiation of these 
cells. One possible explanation for this finding is that α4β1 and α4β7 might have 
redundant functions in early hematopoiesis and that only the absence of both 
molecules impairs lymphopoiesis. To address this question in this study, β1β7 
mutant BM chimeras were generated and lymphopoiesis was examined. 
Surprisingly, B cell development occurred normally in β1β7 mutant BM chimeric 
mice. Pre-B cell colony assays revealed that pre-B cell colonies can form in vitro 
in the absence of β1 and β7 integrins and that the knockout efficiency at this stage 
of B cell development was similar to the deletion efficiency on mature B cells as 
assessed by Southern blot indicating no developmental defects in between these 
stages. Immature (B220 medium) and mature (IgD+) β1 and β7 integrin deficient 
B cells were present in the β1β7 mutant BM chimeras even 12 month after 
induction of the knockout, demonstrating that B cell development in vivo can 
continue to mature stages in the absence of both β1 and β7 integrins. Clearly, 
α4β1 and α4β7 are not required for B cell development. One explanation for the 
contrasting results could be that the loss of β1 integrin receptors in addition to 
α4β1 rescues the α4-null phenotype. The decrease in transmigration through the 
BM stroma observed with α4-null progenitor cells could, for example, be due to 
increased adhesion to fibronectin via α5β1. An alternative explanation is the use 
of different experimental systems. In somatic chimeras, also non-hematopoietic 
cells can be α4 integrin deficient including, for example, BM stroma cells. BM 
stroma cells are known to be important in the regulation of hematopoiesis by 
producing hematopoietic cytokines and by direct cell-cell contact with HSC and 
HPC. It might be that loss of α4 integrin on non-hematopoietic cells leads to the 
production of cytokines inhibiting B cell development. Thirdly, if pre-pro-B cells 
(B220-, CD19-, IgM-) in β1β7 mutant BM chimeras express α4 in the absence of 
β1 and β7 integrin; this could result in a rescue of the α4 null phenotype. 
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However, using a 4-colour FACS we cold not test this directly. Finally, it cannot 
be excluded that in these somatic chimeras α4 deficient lymphocyte precursors 
develop, but have a competitive disadvantage against α4 positive RAG-1 deficient 
cells. Mice lacking α4 integrin in the hematopoietic system and in other tissues 
were reported to have a slight, but significant reduction in B220+ cells in the BM 
from 24.9% in control to 20.8% in α4 mutant animals (Scott et al., 2003). 
However, since no further information about B cell subpopulations was provided, 
it is not clear whether the reduction in B cell numbers corresponds to a 
developmental or a migratory defect. Since the α4 deletion was not restricted to 
the hematopoietic system, the loss of α4 integrin on other cells could attribute to 
the differing results.  
After 10-12 months, BM of β1β7 mutant BM chimeras contained less immature B 
cells than control animals while the relative amounts of all other B cell 
subpopulations remained the same. Whether there is a defect in B cell 
development that is not apparent at 2 months, but only becomes apparent 10-12 
months after the β1 integrin gene deletion or whether these variations are due to 
individual changes in B cell progenitor frequency from one donor mouse to 
another remains to be determined. The donor mice were outbred, i.e. genetically 
not identical, and it is known that the genetic background influences the size of 
hematopoietic cell compartments (Henckaerts et al. 2004). More mice should be 
analysed to test whether there really is a change in immature B cell numbers. 
 
Several results proposed an important role of α4 integrins in T cell development. 
First, α4-null T cell precursors are unable to exit the BM. The normal thymus of 
β7-null mice suggests that the emigration of T cell precursor might be mediated 
by α4β1. Secondly, the migration of T cell precursors from the blood to the 
thymus was proposed to be at least partially mediated by α6β1 integrin (Ruiz et 
al., 1995). Finally, adhesion and migration of thymocytes within the thymus were 
suggested to be dependent on a coordinated engagement of α4β1 and α5β1 
(Salomon et al., 1994; Crisa et al., 1996). In contrast to these models, T cell 
precursors deficient for β1 integrin can leave the BM, are able to migrate to and 
even to develop normally within the thymus implying functional redundancy 
between β1 and β7 integrins (Brakebusch et al., 2002). The analysis of β1β7 
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mutant BM chimeras in this study revealed that also in the absence of both α4β1 
and α4β7, T cell precursors are generated. Furthermore, β1-β7- T cells precursors 
migrate from the BM to the thymus and mature within the thymus to CD4+ or 
CD8+ T cells. These findings are in sharp contrast to the expectations raised by 
the somatic α4-null chimera, which showed a complete block in migration of T 
cell precursors from the BM. In α4 integrin conditional knockout mice, CD4+ T 
cells were reduced from 1.7% in controls to 1.0% in α4 mutants in the BM. Albeit 
no specific developmental block was reported, these data indicate that T cell 
precursors can exit the BM in the absence of α4 integrins. Whether there is a 
defect in T cell development or migration, however, is not clear. Loss of α4 
integrin on non-hematopoietic cells could be the reason for the reduced number of 
T cells in the BM that we could not detect in β1β7 mutant BM chimeras lacking 
α4β1 and α4β7 restricted to the hematopoietic system. Furthermore, expression 
of α4 on β1-β7- T cell precursors migrating from the BM might contribute to 
these differences. 
Alpha4 integrins are therapeutic targets in the treatment of the autoimmune 
diseases Multiple Sclerosis and Crohn’s disease. Inhibitory antibodies against α4 
integrin are currently tested in long term studies (Andrian et al. 2003). This 
treatment, however, does not lead to impaired B or T cell development which is in 
agreement with the normal lymphoid development observed in β1β7 mutant BM 
chimeras. 
 
 
4.3 Lymphocyte migration 
 
Lymphocytes extravasate by weakly binding to and rolling on the endothelium, 
followed by integrin activation, integrin mediated firm adhesion, and 
transmigration through the endothelial cell layer and the underlying basement 
membrane (Moser and Loetscher, 2001). Although β1 integrin is crucial for the 
adhesion of HSC to the endothelium of hematopoietic organs (Hirsch et al., 1996; 
Potocnik et al., 2000), it was not known whether it plays a similar role in 
differentiated lymphocytes. Since antibodies against the basement membrane 
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component laminin reduced lymphocyte emigration to lymph nodes in vivo 
(Kupiec-Weglinski and De Sousa, 1991) and adhesion to basement membrane 
laminins correlated with the ability of T cells to transmigrate these barriers (Sixt, 
2001). It was also suggested that β1 integrin-mediated binding of extravasating 
cells to basement membrane components like laminin is crucial for this process. 
The analysis of BM, spleen, LN and PP of β1-null BM chimeras did not confirm a 
role of β1 integrin in lymphocyte trafficking because the β1 mutant animals 
showed normal amounts of lymphocytes in secondary lymphoid organs 
(Brakebusch et al., 2002). Competitive lymphocyte migration assays with β1-null 
cells did not reveal significant differences in short term homing of β1-deficient 
and normal cells to spleen, LN and PP, suggesting that β1 integrin on 
lymphocytes is dispensable for firm adhesion to and transmigration through the 
endothelium and the basement membrane. It is possible that the migration through 
the basement membrane does not require binding to this structure, but rather local 
protease activity enabling cell movement without specific contact of cellular 
receptors and basement membrane molecules (Friedl and Brocker; 2000).  
In mice deficient for the β7 integrin subfamily the formation of the gut associated 
lymphoid tissue (GALT) is severely impaired. It was shown that α4β7 integrin 
expressed on lymphocytes contributes to the rolling, but not to the initial binding 
of these cells on the high endothelial venules of the gut, which are the entry points 
for leukocytes into the GALT. In addition, it was suggested that β7-null 
lymphocytes fail to adhere firmly to the high endothelial venule of the gut 
(Wagner and Müller et al., 1996). The mucosal counter receptor for α4β7 is 
MAdCAM-1 and, as expected, mice not expressing MAdCAM-1 show a similar 
absence of GALT as β7-deficient mice (Pabst et al., 2000).  
β1β7 mutant lymphocytes were found in all lymphoid organs besides PP 
demonstrating that α4β1 and α4β7 are not essential for lymphocyte circulation. A 
reduced number of B cells were observed in LN 10-12 months after induction of 
the knockout, however, no defect was observed 2 months after knockout 
induction. Short-term homing assays should be carried out to verify whether β1 
and β7 deficient B cells have an impaired migration to LN. All other lymphoid 
organs showed similar percentages of β1β7 deficient B cells, suggesting normal 
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migration of β1β7 mutant B cells to the spleen and normal recirculation to the 
BM. 
The percentage of β1β7-deficient CD4 or CD8 T cells was similar in BM, spleen 
and lymph nodes 2 and 10-12 months after knockout induction. However, the 
amount of CD4 T cells observed in LN 10-12 months after induction of the 
knockout was slightly increased. Since only 3 mice have been analysed, it cannot 
be definitely concluded whether T cell migration to LN is altered in mice 10-12 
months after the gene deletion or whether relative T cell numbers are influenced 
by the amount of B cells homing into this tissue. It seems, however, that β1 and 
β7 integrins are dispensable for the circulation of T cells under non-inflammatory 
conditions.  
VCAM-1-deficient mice were reported to have a defective migration of mature B 
cells to the BM (Koni et al., 2001; Leuker et al., 2001).  The cell surface receptor 
VCAM-1 can bind to α4β1, α9β1 and α4β7. However, ablation of all three 
receptors in the β1β7 mutant BM chimeras did not reproduce the phenotype 
described for the VCAM-1-deficient mice, indicating an additional VCAM-1 
binding partner responsible for it or an indirect mechanism not involving a direct 
interaction of VCAM-1 on endothelial cells with a counter receptor on 
lymphocytes.  
 
 
 
4.4 Development of myeloid cells 
 
In vitro experiments demonstrated that antibodies against α4β1 delay myeloid 
development in vitro (Miyake et al., 1991). In accordance with this data a low 
steady state level of differentiated myeloid cells was described for α4 deficient 
chimeric mice (Arroyo et al., 1999). In the BM of one month old somatic chimeric 
mice the contribution of α4-deficient myeloid cells was lower than 10% compared 
to an average chimerism of more than 30% in all other tissues. Since no 
developmental defect for myeloid cells was described for β7 integrin deficient 
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mice (Wagner et al., 1996) the defects found in α4 null chimeric mice were 
suggested to be caused by the loss of α4β1 integrin.  
α9β1 integrin, which is highly expressed on human neutrophils and can bind to 
VCAM-1, was shown to promote transendothelial migration of neutrophils in 
vitro (Taooka et al., 1999). It was therefore possible, that loss of β1 integrin leads 
to an accumulation of neutrophils in the blood. In contrast to this hypothesis, β1 
mutant BM chimeras showed a completely normal development of myeloid cells 
and displayed no accumulation of neutrophils in the peripheral blood (Brakebusch 
et al., 2002). Since also β1β7 mutant BM chimera displayed normal myelopoiesis, 
there is no evidence for a redundant function of α4β1 and α4β7 with respect to 
differentiation of this blood cell lineage. A closer look at the deletion efficiency of 
β1 integrin in the β7 null background among immature granulocytes shows that 
the amount of β1 and β7 integrin deficient cells decreases from 94.4%±4.7% 2 
months after the gene deletion to 90.7%±2.7% after 10-12 months after the gene 
deletion. However, different mice were mice were tested at these time points so 
that this slight difference is most likely due to mouse to mouse variations and not 
caused by a competitive advantage of β7- over β1-β7- myeloid progenitors. 
Although α4 integrin is not important for erythropoiesis in colony assays in vitro, 
it was reported to be absolutely required in erythropoiesis in vivo since in adult 
α4-null somatic chimeras no erythrocytes derived from α4-null HSC could be 
found. In β1β7 mutant BM chimeras, erythroblast formation was not impaired. 
Erythrocyte numbers in BM and spleen were normal, but it was not possible to 
confirm in this system that the erythrocytes are derived from β1- β7- progenitors 
or, although rather unlikely, from the low number of β1 expressing precursor 
cells. Normal numbers of Ter119+ erythroblasts were also reported in the 
conditional α4 knockout mice, however, the origin of the erythrocytes was not 
investigated (Scott et al., 2003).  
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4.5 Surface expression of α4 integrin in the absence β1 and β7 
integrins 
 
Integrins are heterodimeric cell surface receptors that are composed of an α and β 
subunit (Hynes 2002). So far, no integrin receptor has been reported to function as 
a monomer. Furthermore there is no evidence from the mouse genome database 
that there are more β integrin subunits than the 8 already known. However, in 
studies using B cell or T cell lymphoma cell lines α4 and α6 integrin were 
observed on the cell surface in the absence of β1 and β7 integrin (Crowe et al., 
1994, Stroeken et al., 1998). Since no β subunit or any other molecule could be 
co-immunoprecipitated with these α chains, it was concluded that α4 and α6 
could be expressed on the cell surface as a monomeric subunit. Alternatively, α4 
or α6 might dimerize with a molecule different from β1 and β7 rather weakly, so 
that the association will be lost under the lysis conditions used. With the presence 
of α4 integrin on the cell surface in β1β7 mutant mice we observe now for the 
first time in untransformed cells an integrin subunit in the absence of its known 
dimerisation partners. To date, it is not clear whether α4 is part of a new 
heterodimer or whether it can reach the cell surface as a monomer. Furthermore, 
no function could yet be ascribed to this α4 chain as α4+ β1- β7- cells do not bind 
VCAM-1 in a Mn2+ inducible manner. Mn2+ inducible binding, however, would 
require a β subunit associated to α4. Therefore this assay does not exclude the 
capability of α4, as part of a heterodimer or as a monomer, to bind extracellular 
ligands. This is difficult to test as the ligand preferences might be different from 
α4β1 or α4β7 integrins. The surface expression of α4 integrin in the absence of 
β1 and β7 integrin was mainly found on erythroblasts, but not on other 
differentiated cells. Since erythroblasts of wild type mice express the highest 
levels of α4 integrin of all hematopoietic cells, α4 expression on β1β7-null cells 
might be due to inefficient intracellular sorting and degradation of the large 
amounts of α4 lacking a conventional partner.  
Also, non-hematopoietic fibroblastoid cells deficient for β1 and β7 can express α4 
on the surface. Whether α4 is present as a monomer or in a complex and whether 
this is similar to the hematopoietic system was not yet investigated. In any case 
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the availability of stable, fibroblastoid α4+β1-β7-, cell lines will facilitate the 
further analysis as they allow the generation of very high cell numbers for 
biochemical analysis without any contaminating wild type cells present in 
conditional knockout mice. 
 
 
 
4.6 Conclusion 
 
In this study the role of β1 and β7 integrins for the hematopoietic system has been 
elucidated using BM chimeric mice in which these two integrins were absent only 
in hematopoietic organs. B cells, T cells, granulocytes and monocytes as well as 
erythrocytes were found to develop normally in these mice despite the absence of 
α4β1 and α4β7. These results were unexpected since α4 null somatic chimeric 
mice have severe hematopoietic defects. Integrin α4 conditional knockout mice 
show milder but significant impairments in lymphopoiesis. Furthermore, α4 
integrin expression on HSCs/HPCs was supposed to be crucial for their retention 
in the BM. Our data suggest that inhibition of α4 integrin on non-hematopoietic 
cells can contribute significantly to the release of HPCs from the BM indirectly 
affecting HPC retention maybe by cytokines. These data completely change the 
previous view of integrin function in blood cell development and contribute to a 
new understanding of the role of these molecules during hematopoiesis.  
The analysis of β1β7 mutant BM chimeras revealed cells expressing α4 in the 
absence of β1 and β7 integrin. To which extent the existence of such cells account 
for the relatively mild phenotype is not yet clear. The focus in the future will be 
on the biochemical analysis of an established α4+β1-β7- fibroblastoid cell line to 
uncover potential binding partners and intra- and/or extracellular ligands and to 
test the importance of these findings for the α4+β1-β7- cells observed in β1β7 
mutant BM chimeric mice. 
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5. Zusammenfassung 
 
Integrine sind im Blutsystem von entscheidender Bedeutung für die Besiedlung 
von hämatopoietischen Organen, für die Entwicklung und Verteilung der 
Vorläuferzellen und für die Extravasation von Leukozyten in entzündete Organe. 
Studien mit somatisch chimären Mäusen mit einer gezielten Inaktivierung des 
Gens für α4 integrin, das mit β1 und β7 heterodimerisieren kann, zeigten, dass α4 
integrin notwendig für normale Hämatopoiese ist. In diesen Mäusen wurden nur 
wenige, α4 defiziente B Zellen gefunden und T Zell-Vorläufer konnten das 
Knochenmark nicht verlassen um im Thymus heranzureifen. Die Entwicklung der 
Erythrozyten war in Abwesenheit von α4 Integrin blockiert und die Expansion der 
myeloiden Vorläuferzellen eingeschränkt. 
Mäuse mit einem Genverlust von entweder β7 oder β1 Integrin nur im 
hämatopoietischen System, zeigten jedoch eine normale Blutzellentwicklung. Um 
zu überprüfen, ob α4β1 und α4β7 funktionell redundant sind, wurden Tiere 
erzeugt, denen beide Untereinheiten, β1 und β7, gleichzeitig im Blutsystem 
fehlen. Dazu wurden Mäuse mit einer β7 Nullmutation mit Mäusen verpaart, die 
eine konditionale Gendeletion für β1 Integrin tragen. Der Verlust der 
funktionellen Gene wurde durch eine Knochenmarkstransplantation auf das 
hämatopoietische System beschränkt. Die resultierenden Knochenmarkschimären 
wurden nach der Repopulation der hämatopoietischen Organe mit polyIC 
behandelt um die Gendeletion zu induzieren. Überraschenderweise konnten keine 
Defekte  in der Entwicklung von Blutzellen gefunden werden. Die Entwicklung 
von B Zellen, T Zellen, Blutplättchen, Erythrozyten, Granulozyten und 
Monozyten wurde untersucht und war unabhängig von β1 und β7 Integrinen. Da 
die Zellularität der lymphatischen Organe von β1β7 mutanten 
Knochenmarkschimären nicht verändert war im Vergleich zu β7 mutanten 
Knochenmarkschimären, die als Kontrollen verwendet wurden, gab es keinen 
Hinweis auf defekte Leukozytenmigration. 12 Monate nach der Induktion der β1 
Integrin Gendeletion wurde keine Expansion der β1 exprimierenden Zellen 
festgestellt, was darauf hindeutet, dass β1+ hämatopoietische Zellen keinen 
kompetitiven Vorteil in Entwicklung und Expansion haben. Die Expansion der 
hämatopoietschen Zellen war sogar nach induzierter Anämie unbeeinträchdigt.  
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Bei der Analyse der β1β7 mutanten Knochenmarkschimären wurden 
hämatopoietische Vorläuferzelln und Erythroblasten gefunden, die α4 
exprimieren, aber negativ sind für β1 und β7 Integrin. Die funktionelle Bedeutung 
dieser α4 Expression ist jedoch unklar, da keine Bindung an VCAM-1 
nachgewiesen werden konnte. Obwohl noch unbekannt ist, ob α4 Integrin auf der 
Zelloberflächefläche mit einem Protein assoziiert ist oder alleine existiert, kann 
durch einen gentetischen Ansatz ausgeschlossen werden, dass es mit β2 Integrin 
heterodimerisiert, welches sehr stark auf hämatopoietischen Zellen exprimiert 
wird. 
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6. Abstract 
 
In the hematopoietic system, integrins are crucial for the colonisation of 
hematopoietic organs, the development and distribution of progenitor cells, and 
for the extravasation of leukocytes into inflamed tissues. Using somatic chimeric 
mice carrying a targeted disruption of the gene for α4 integrin, which is known to 
dimerize with either integrin β1 or β7, α4 integrins were shown to be crucial for 
normal hematopoiesis. In these mice only few α4-null B cells were detected and T 
cell precursors could not leave the BM for maturation in the thymus. Furthermore, 
erythrocyte development was blocked and expansion of myeloid progenitors was 
reduced in the absence of α4 integrins. 
Mice with a knockout of β7 or β1 integrin restricted to the hematopoietic system, 
however, have no defects in hematopoiesis. To test whether α4β1 and α4β7 
integrins have redundant functions β1 and β7 double knockout mice were 
generated by intercrossing mice with a constitutive β7 knockout and a conditional 
ablation of β1. To restrict the deletion to the hematopoietic system, BM chimeric 
mice were generated. The deletion of the β1 integrin gene was induced after 
repopulation by repeated injections of polyIC. Surprisingly, no defects in the 
hematopoietic development of β1β7 mutant BM chimeras were noted. 
Development of B cells, T cells, platelets, erythrocytes, granulocytes and 
monocytes was unimpaired in the absence of β1 and β7. Normal cellularity of 
lymphoid organs indicated no obvious defect in leukocyte migration. No 
expansion of β1 expressing cells was noted 12 months after the induction of the 
β1 integrin gene deletion, suggesting no competitive advantage of β1+ 
hematopoietic cells. Finally, normal expansion of hematopoietic cells was 
observed after acute haemolysis. 
Unexpectedly, HPCs and erythroblasts were found which express α4 integrin on 
the surface in the absence of β1 and β7 integrin. This α4 integrin was not able to 
mediate binding to VCAM-1 and it is therefore unclear, whether it is of functional 
importance. Using a genetic approach we could show that this α4 integrin is not 
heterodimerizing with β2 integrin, which is strongly expressed on hematopoietic 
cells. 
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These data indicate that α4β1 and α4β7 are not required for hematopoiesis and do 
not have essential overlapping functions. The severe phenotype reported for α4 
null somatic chimeric mice might be caused by the loss of α4 integrin on non-
hematopoietic cells, while in our system the ablation of β1 and β7 integrin is 
restricted to the hematopoietic system. 
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